=============================================================================================================

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

x           ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
                
FOR THE YEAR ENDED JUNE 30, 2008

Commission file number 000-27094

FIRST AMERICAN SCIENTIFIC CORP.
(Exact name of registrant as specified in its charter)

NEVADA
(State or other jurisdiction of incorporation or organization)

# 26 - 7621 Vantage Way
Delta, British Columbia
Canada V4G 1A6
(Address of principal executive offices, including zip code.)

(604) 940-6220
(Registrants telephone number, including area code)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
YES ¨ NO x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act:
YES ¨ NO x

Indicate by check mark whether the registrant(1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 day. YES x NO ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulations S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy ir information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 if the Exchange Act.

Large Accelerated Filer   ¨ Accelerated Filer   ¨
Non-accelerated Filer   ¨ Smaller Reporting Company   x
(Do not check if a smaller reporting company)      

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). YES [ ] NO [X]

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was sold, or the average bid and asked price of such common equity, as of September 30, 2008: $3,997,043.

=============================================================================================================

 

 


 

 

TABLE OF CONTENTS
 
    Page  
 
  PART I    
Item 1.   Description of Business.   3  
Item 1A.   Risk Factors.   10  
Item 1B.   Unresolved Staff Comments.   12  
Item 2.   Properties.   12  
Item 3.   Legal Proceedings.   12  
Item 4.   Submission of Matters to a Vote of Security Holders.   12  
 
  PART II    
Item 5.   Market Price for the Registrant’s Common Equity, Related Stockholders Matters    
  and Issuer Purchases of Equity Securities.   12  
Item 6.   Selected Financial Data.   15  
Item 7.   Management’s Discussion and Analysis of Financial Condition and Results of    
  Operation.   15  
Item 7A.   Quantitative and Qualitative Disclosures About Market Risk.   20  
Item 8.   Financial Statements and Supplementary Data.   20  
Item 9.   Changes in and Disagreements With Accountants on Accounting and Financial    
  Disclosure.   42  
 
  PART III    
Item 9A.   Controls and Procedures.   42  
Item 9B.   Other Information.   44  
Item 10.   Directors and Executive Officers, Promoters and Control Persons.   44  
Item 11.   Executive Compensation.   47  
Item 12.   Security Ownership of Certain Beneficial Owners and Management.   50  
Item 13.   Certain Relationships and Related Transactions, and Director Independence.   51  
Item 14.   Principal Accounting Fees and Services.   51  
 
  PART IV    
Item 15.   Exhibits.   52  

 

 

 

-2-

 

 


 

      PART I

ITEM 1. DESCRIPTION OF BUSINESS

General

      FIRST AMERICAN SCIENTIFIC CORP. (the “Company”) was incorporated under the laws of Nevada on April 12, 1995. The Company owns the patented kinetic disintegration system called the KDS Micronex System and two additional process patents using the equipment. One other process patent application is pending. The System consists of an electrically powered disintegration/drying chamber and feeding system that utilizes kinetic energy and standing sound waves to pulverize various waste materials such as biomass (wood waste), pulp sludge, animal waste, food waste, rubber, glass, and other feed stocks into valuable, fine, dry, talcum-like powders that can be used as a combustible fuel or a high nutrient fertilizer. The goal of the Company is to identify and develop commercially viable “waste to resources” industrial applications for the KDS System, then market, manufacture, sell, lease and/or license it to end users in the forest and pulp and paper industries, in agriculture, in recycling, and others.

Applications of the KDS System

1. Converting Biomass to Combustible Fuel or Fertilizer

      The Company's research and testing to date indicates that the highest potential use for the equipment is found in pulverizing and drying (micronizing) biomass (wood waste) into a fine, dry combustible fuel that can be incinerated in specialized burners to create BTUs (heat energy), which, in turn, can be converted to electrical power through conventional means. For biomass, the critical value of the process is its ability to act as an industrial dryer which can extract water from wood at below boiling temperature at a significantly lower cost than through other conventional methods.

2. Drying and Grinding of Pulp Sludge

      The Company has also processed wet (80% moisture) pulp sludge, and has shown that potential exists in converting waste pulp sludge to a dry, fibre-like powder and releasing the kaolin clay concurrently, then burning to create BTUs which are recycled back into the paper making process as heat and/or electrical power. This could reduce energy costs, disposal costs, and environmental problems in the pulp and paper industry.

3. Drying and Grinding Animal Waste/Munincipal Sewage/Food Waste

      When micronizing animal manures, the system has proven its ability to kill 99% of all pathogens and coliforms during processing earning it an EPA rating as a pesticide device with registered establishment number 73753 CAN - 001 granted to the Company in January 2001. This “cleansing” of these types of waste products could bring large animal and poultry producers into compliance with EPA regulations as well as create a nutrient rich "clean" end product suitable for recycling as fertilizer. When micronizing a mixture of food waste, wood waste and chicken manure, a fine, dry, pathogen-free dry powder is produced which is suitable as a high nutrient fertilizer base, as a filler, or, depending on the content, as cattle feed.

 

-3-

 


 

4. Pulverizing of Mineral Rock to Release Precious Metals

      When micronizing mineral rock, the process reduces the rock to a consistent fine dry powder as small as -400 mesh which has proven sufficient to separate and release precious and heavy metals mechanically without the use of chemicals. Development work continues to increase the durability of the equipment to withstand the heavy wear imposed when processing hard rock. Although the process has proven to be 97% efficient, commercially viable processing volumes have not yet been achieved. This process has now been patented.

5. Micronizing Scrap Rubber

      When micronizing rubber, a cryogenic cooling process can facilitate the recycling of scrap rubber by pre-freezing it in a cooling chamber and injecting it through a pneumatic feed system into a pulverizing chamber. The method has proven that the KDS system can pulverize (shatter) rubber into a fine mesh suitable for re-cycling as a base material for other rubber based products. Commercially viable quantities are not yet proven. This process has now been patented and the company is seeking a joint venture partner who will participate in the development of this application to commercial viability. No further work has been done this year, and the application is dormant.

6. Micronizing of Recycled Glass

      When micronizing glass, the process reduces it to a consistent fine dry powder as small as 20 microns which has proven valuable as a strengthener in asphalt, concrete and ceramics.

The KDS Equipment

      The KDS uses a patented high speed rotary action to create sufficient kinetic energy to pulverize and dry (micronize) raw materials that are introduced into the chamber without cutting.

      The KDS machine weighs approximately five tons and measures sixteen feet high, by ten feet long by eight feet wide. It is powered by a 150 or 250 hp main drive electric motor and uses 5 smaller ancillary motors to move product though the chamber and out through the taurus. The feed material is typically one inch in diameter and carried by a pneumatic lift or conveyor and material grading system, passing through the KDS system at various rates, dependent up product size, moisture content and hardness. The life span of the KDS machine is greater than ten (10) years and requires ongoing service and replacement of consumables on a daily basis. Maintenance is minimal and requires less than thirty minutes per day and twenty-four hour servicing twice a year.

      There are currently three models and variations thereof available designed for various feedstocks and applications.

 

-4-

 


 

Patents issued and pending

Device and Method for Comminution - US Patent #6,024,307 and Canadian patent # 2,218,429

      A patent was issued for the KDS as for a “device for comminution” on November 24, 1998, and its U.S. patent number is 6,024,307 with additional patent applications filed in Australia, Canada, Europe (EEC), Finland, France, Germany, Ireland, Italy, Mexico, New Zealand, Spain, Sweden, Switzerland, and the United Kingdom.

Cryogenic Comminution of Rubber - US Patent # 6,655,167 B2

      On April 20, 2001, the Company filed a patent application in the United States to protect its research into developing a process for cryogenically freezing non-tire scrap rubber and processing in into a micro-fine powder using the KDS equipment. This patent has been issued.

Method of Recovery of Precious Metal and Heavy Minerals - US Patent # 6,682,005 B2

      On May 4, 2001, the Company filed a patent application in the United States to protect its research into developing a process for disintegrating and separating precious metal from hard rock without the use of chemicals. This patent has been issued.

Method and apparatus for Recovery of Fuel and Clay from Biomass - (pending)

      In November 2002, the Company filed a provisional patent application in the United States to protect its research for the processing wet biomass through the KDS equipment. Some of the subject matter in the application has been approved and a new patent is pending.

Acquisition of/Ownership of Patents

      On June 22, 1995, the Company entered into a license agreement with Spectrasonic Corp. (hereinafter “Spectrasonic”), a related party, for the worldwide license to its unpatented KDS for use in rubber and glass recycling and disposal, for a period of ninety-nine years.

      On February 22, 1996, the Company entered into an additional license agreement with Spectrasonic for the worldwide license to its unpatented Ultrasound Equipment for exclusive use in gypsum disintegration, disposal, recycling, remanufacturing or manufacturing of used or new raw materials.

      On July 2, 1997, the Company purchased from Spectrasonic Corp all rights to the technology and its patents, whether issued or pending, including all data pertaining to the patent process with respect to the KDS Disintegration System. Upon the final payment to Spectrasonic of 1,000,000 common shares of the Company’s stock valued at $0.25 per share which was made on December 1, 1999, unencumbered right and title to all patents was irrevocably transferred to the Company.

 

 

-5-

 


 

Research and Testing

      The Company continues research with various materials to improve operating efficiencies; increase volume throughput to economically viable levels; and identify markets where profitable operation of the equipment can be achieved. Of particular interest is adapting the equipment to dry out heavily moisture laden materials such as biomass from the forest industry, and pulp sludge. In this regard, testing is being carried out in Canada by FASC in Kuala Lumpur, Malaysia by FASCM, in London, England by WRAP, in Japan by JP Steelplantech, and in Korea by JNK Heaters Ltd. Significant progress has been made converting biomass to a fine dry fuel which can be combusted in the dust burning system. All research on rubber processing has been discontinued until a suitable research partner can be identified.

Government/Environment Regulation

      The Company is subject to various federal, provincial and local environmental laws and regulations. Management believes that the Company’s operations currently comply in all material respects with applicable laws and regulations. Management believes the trend in environmental litigation and regulation is toward stricter standards, and that these stricter standards may result in higher costs for the Company and its competitors. Such changes in the laws and regulations may require the Company to make additional capital expenditures which, while not presently estimable with certainty, are not presently expected to be material. Costs for environmental compliance and waste disposal have not been material in the past. In the future, stricter regulations may increase the demand for our products which offer solutions to some environmental problems.

Manufacturing

      Canadian manufacturing of the KDS machine is sub-contracted to Mainland Machinery Limited (MML) in Abbotsford, British Columbia at a fixed price on a case by case basis. Engineering and design assistance are also provided by MML. Our licenses in Malaysia and Japan provide for local manufacturing in those countries subject to certain conditions.

Technology Licenses granted as of June 30, 2005

Canada - Alternative Green Energy Systems Inc

      In October 2001, the Company signed an agreement with Thermix Combustion Systems Inc, to form a jointly owned corporation named the Alternative Green Energy Systems Inc. (“AGES”). AGES goal was to adapt the KDS system to create a continuous flow of suitable micronized hog fuel/ wood dust that will be used as a fuel for Thermix’s specialized dust burners. FASC and Thermix contributed their respective technologies to design a complete micronizing and dust burning system to be marketed to the Thermix’s contacts in the pulp industry.

      In February 2002, the Company granted a conditional license to AGES to manufacture and sell the KDS equipment for all applications using biomass in Canada, the USA, and the European Union. In February 2002, AGES signed an agreement with Hydro Quebec Capitech Inc. wherein Hydro Quebec Capitech agreed to invest CDN$1,000,000 equity in AGES's for research and development. On February 21, 2004, that license expired when conditions were not met.

 

 

-6-

 


 

      On February 23, 2004, the Company granted AGES a modified exclusive license to design, manufacture and sell a large scale version of the KDS machine to be used in the pulp and paper industry in Canada, the USA, and the European Union.

      In fiscal year 2006, AGES did not sell the required one machine per year, but paid $25,000 in lieu of a sale to maintain its exclusive rights granted under the agreement, but by mutual agreement, in July 2006, the license was modified to reduce the territory licensed to Canada and the USA.

      In fiscal 2007, Hydro Quebec Capitech, one of the AGES partners exercised it right under a put clause in the shareholder agreement, causing 100 % of AGES shares to be sold to a third party for one dollar plus assumption of over $1,000,000 of debt. As a result, the Company’s shareholdings in AGES wetre reduced to zero. As of the date of writing, the new owner of AGES has not paid the license fee and the license is still in default and subject to be cancelled.

      Under the license agreements with AGES, the Company retains ownership of all patents for the KDS technology, and owns rights to all the research conducted by AGES.

     This license was cancelled for non-performance in September 2008.

Malaysia - FASC ( Malaysia ) SDN. BHD.

      On July 8, 2004, the Company granted an exclusive license for 21 years to First American Scientific Corp (Malaysia) Bhd. Sdn., to market the KDS system in Malaysia, Thailand, Singapore and Indonesia. The agreement required FASCM to purchase one KDS machine and set up a fully operational demonstration plant in Malaysia. This requirement was met in September 2004.

     As of June 30, 2008 , FASC owns 50 % of the outstanding shares of FASCM.

Japan - JP Steelplantech Co. Ltd .

      On September 26, 2005, the Company granted an exclusive license for manufacturing and marketing the KDS System in Japan to JP Steelplantech Company of Yokohama, Japan. As part of the licensing agreement, JP Steel paid an up front licensing fee and purchased and installed a fully operational KDS at its facility in Yokohama to be used for sales demonstrations and research purposes. JP Steel will also pay a royalty for each machine manufactured and sold in Japan. Marketing efforts are now underway.

      JP Steel Plantech Co. is a well established engineering and equipment manufacturing company owned by four Japanese steel industry companies ; Kawasaki Heavy Industries (KHI), Hitachi Zosen (HITZ), JFE Engineering (JFE) and Sumitomo Heavy Industries (SHI).

Korea - JNK Heaters Co. Ltd dba FASC – Korea

    This license was cancelled for non-performance in April 2008.

 

-7-

 


 

Brazil

      On April 18, 2006, the Company announced the anticipated signing of an Agreement in Principle to form a joint venture to be named First American Scientific Brazil Ltda. for the manufacture, marketing, and operation of KDS equipment in Brazil, Uruguay and Argentina. This agreement was never finalized as the parties could not agree on certain terms therein. The group, however, purchased one machine which was delivered in June 2007 and negotiations are expected to re-open this calendar year.

Summary of Agreements

     Other material contracts or agreements:

The Waste and Resources Action Programme B UK (WRAP)

      In September 2004, we signed an agreement wherein WRAP has agreed to provide funding to develop “value enhanced end-products” from the output of the KDS machine. WRAP has agreed to provide $1,000,000 USD for the purchase and installation of one complete KDS system to be located at a local pulp & paper mill in England. The fund will also pay for market research, scientific research, redesign and adaptation costs for the equipment and supplementary systems for industry-specific applications. The goals of the project are to demonstrate the KDS technology in a working environment, optimize ancillary equipment to improve its efficiency, and identify markets for recycled end products. In December 2004, a KDS Model S-4 was shipped to Aylesford Newsprint in London, England for trial runs and evaluation. The testing is now complete and a final report was issued in April 2007.

City of Prince George, Canada

      FASC has signed a Memorandum of Understanding the City of Prince George, BC, Canada to assist in solving its environmental cleanup problems with sewage sludge using the KDS Micronex system. This will be the first operation of its kind in the world where the strictly regulated Class B municipal sludge can now be cleaned, bagged and profitably sold to the public as a soil amendment. The initial runs will be monitored for two months, and if satisfactory, the city will establish a permanent facility and purchase up to 4 KDS Micronex machines. To date all trial runs have been satisfactory and many adjustments have been made to accommodate the efficient processing of the sewage sludge. The project is now entering Phase 2 to redesign and modify the equipment to improve its drying capabilities. This design work is now underway.

Market

      The KDS machine has proven viable for softer industrial rock, such as gypsum and zeolite, wood chips or chicken manure (embedded in sawdust), and any biomass at moisture levels below 60%. The Company continues to research and seek potential markets where operation of the equipment is economically viable. Improvements to the equipment continue and we are constantly experimenting to find solutions that increase throughput on various types of products. Each situation presents unique hurdles to be overcome. In the case of rubber, feedstock becomes elastic with rise in temperature and must be pre-frozen before processing to maintain efficient shattering. In the case of biomass and pulp sludge, the product must not exceed 60% moisture content to avoid clogging of the equipment. In the case of minerals rock, chains must be replaced with hardened steel bars to avoid rapid wear and breakage. In the case of human and animal waste, a de-watering is required prior to processing. Some of these adaptations require additional research and until implemented, there is no certainty that the equipment will be accepted in all the proposed markets.

 

-8-

 


 

Competition

      The Company has competition from other producers of microfine powders, most of who must use a series of equipment to achieve similar results. Some have much greater financial resources than the Company, but the Company believes its system is more cost effective than these competitors and that we can reasonably expect to attract a share of the marketplace.

Company Facilities

      The Company's offices are located at # 26 – 7621 Vantage Way, Delta, British Columbia, Canada, V7T 1A2. The phone number is (604) 940-6220, respectively. The fax number is (604) 940-6221.

Subsidiaries and other equity positions

Canada - First American Scientific ( Canada ) Ltd.. - 100 % owned by FASC

      The Company owns 100% of the outstanding shares of common stock of First American Scientific (Canada) Ltd, a BC company which was formed for the purpose of providing research, development, and other services to FASC and its Canadian customers and licensees. The Company changed its name from First American Power Corp to First American Scientific (Canada) Ltd. on May 26, 2005.

Malaysia - FASC (Malaysia) Bhd. Sdn. - 50 % owned by FASC

      The Company owns 50% of the outstanding shares of common stock of First American Scientific (Malaysia) Bhd. Sdn. (FASCM) , a Malaysian company incorporated for the purpose of manufacturing and marketing the KDS system in Malaysia, Thailand, Singapore, and Indonesia primarily to the palm oil industry.

Canada - Alternative Green Energy Systems Inc (AGES) - 0 % owned by FASC

     The Company no longer has any shareholdings in AGES.

Employees

      FAS (Canada) Ltd. currently has two full-time employees in Canada. Messrs. Nichols, Kantonen and Gibson are officers of, and members of the boards of directors of both FASC and FAS (Canada) Ltd. The Company also retains outside consultants when necessary.

Other

      During the fiscal period ending June 30, 2008, the Company settled various accounts owing by issuance of common stock.

 

-9-

 


 

ITEM 1A. RISK FACTORS.

Risk Factors

      1. Going Concern Opinion. At this time, the Company cannot be sure that it will be successful in its operations. Therefore the Company's independent certified public accountants have issued an opinion that there is substantial doubt about the Company's ability to continue in business as a going concern.

      2. Development and Market Acceptance of New Products. The Company's success and growth will depend upon its ability to improve and market its KDS machines and KDS processes and to successfully develop, and generate revenues from its processes. To date the Company has been unable to achieve the foregoing.

      3. Liquidity; Need for Additional Financing. The Company believes that it will need additional cash during the next twelve months. If the Company is unable to generate a positive cash flow before its cash is depleted, it will need to seek additional capital. There is no assurance that the Company will be able to obtain additional capital if required, or obtain the capital on terms and conditions acceptable to it. The Company is currently suffering from a lack of liquidity and negative cashflow currently being supported by loans from its Directors. In spite of this negative working capital, the Company continues its sales efforts while it continuously seeks out new capital sources. The Company’s auditors have also issued a going concern opinion.

      4. Dependence on Suppliers. The Company relies on a number of suppliers to provide certain raw materials for its products. The interruption of certain sources of supply or the failure to adapt materials to the Company’s changing technological requirements could disrupt the Company’s ability to manufacture products or cause the Company to incur costs associated with the development of alternative sources, either of which could adversely affect the Company's financial performance.

      5. Technology Risk. All manufacturers, including the Company, utilize different applications of known technology. Should a competitor develop a technology breakthrough that cannot be adapted to the Company's systems or develop a more effective application of existing technology, the KDS and its processes would be at risk of becoming obsolete.

      6. Competition. Most of the competition are companies with substantially greater financial, technical and marketing resources than the Company. If the market for the KDS or its process are established, the Company expects that additional competition will emerge and that existing competitors may commit more resources to those markets.

      7. Issuance of Additional Shares. At June 30, 2008, there were 199,852,185 shares of common stock or 99 % of the 200,000,000 authorized shares of common stock of the Company outstanding and less than 150,000 shares remain unissued. The board of directors has the power to issue such shares, subject to shareholder approval, in some instances. Although the Company presently has no commitments, contracts, or intentions to issue any additional shares to other persons, other than in the exercise of options, the Company may in the future attempt to issue shares to acquire products, equipment, or properties, or for other corporate purposes. Any additional issuance by the Company, from its authorized but unissued shares, would have the effect of diluting the interest of existing shareholders.

 

-10-

 


 

      8. Indemnification of Officers and Directors for Securities Liabilities. The Articles of Incorporation of the Company provide that any director, officer, agent and/or employee will be indemnified as to those liabilities and on those terms and conditions as are specified in the Company Act of the State of Nevada. Further, the Company may purchase and maintain insurance on behalf of any such persons whether or not the Corporation would have the power to indemnify such person against the liability insured against. The foregoing could result in substantial expenditures by the Company and prevent any recovery from such officers, directors, agents and employees for losses incurred by the Company as a result of their actions. Further, the Company has been advised that in the opinion of the Securities and Exchange Commission, indemnification is against public policy as expressed in the Securities Act of 1933, as amended, and is, therefore, unenforceable.

      9. Cumulative Voting, Preemptive Rights and Control . There are no preemptive rights in connection with the Company’s common stock. Shareholders may be further diluted in their percentage ownership of the Company in the event additional shares are issued by the Company in the future. Cumulative voting in the election of Directors is not provided for. Accordingly, the holders of a majority of the shares of common stock, present in person or by proxy, will be able to elect all of the Company’s board of directors.

      10. No Dividends Anticipated. At the present time the Company does not anticipate paying dividends, cash or otherwise, on its Common Stock in the foreseeable future. Future dividends will depend on earnings, if any, of the Company, its financial requirements and other factors.

      11. Lack of Market Research. The Company has neither conducted nor has the Company engaged other entities to conduct market research such that management has assurance market demand exists for the transactions contemplated by the Company.

      12. Product Liability. The Company could incur liability for product defects, which result in damage from the use of its equipment and products. Any such claims, if successful, could result in substantial losses to the Company.

      13. No Insurance Coverage. The Company, like other companies in its industry, is finding it increasingly difficult to obtain adequate insurance coverage against possible liabilities that may be incurred in conducting its business activities. At present, the Company has not secured any liability insurance. The Company has potential liability from its general business activities, and accordingly, it could be rendered insolvent by serious error omission.

      14. Non-arms Length Transactions and Conflicts of Interest. The Company has not engaged in any transactions with its officers, directors and principal shareholders except for accepting non-interest bearing loans from two of its officers. Such transactions may be considered as not having occurred at arms length. The Company will be engaged in transactions with management and others involving conflicts of interest, including conflicts on salaries and other payments to such parties.

      15. Reliance Upon Current Management. The Company’s current operations and future success are greatly dependent upon the participation of its officers, Messrs. Nichols, Kantonen and Gibson.

      16. Lack of Key Man Insurance. The Company has not obtained key man life insurance on the life of its officers and directors. The death or unavailability of any one of them could have a material adverse impact on the operation of the Company.

 

-11-

 


 

ITEM 1B. UNRESOLVED STAFF COMMENTS.

      We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.


ITEM 2. DESCRIPTION OF PROPERTIES

      The Company rents a sales office at # 26 - 7621 Vantage Way in Delta, British Columbia, Canada containing 800 square feet of office space for a monthly rental of US$ 650. A new permanent demo facility has been set up in Abbotsford, British Columbia, Canada adjacent to our fabricator.

      As of October 30, 2008, the Company owns one KDS test machine which is installed at the Abbotsford demonstration site and has one machine in the progress of being fabricated which has been sold

      The Company also owns tools, test equipment, a delivery truck, a coverall building, office furniture and office equipment costing at total of $236,383 ( including the KDS test machine) located in Delta, British Columbia, Canada and Abbotsford, British Columbia, Canada

      The Company’s registered office is # 700 - 101 Convention Center Drive, Las Vegas, Nevada 89109.


ITEM 3. LEGAL PROCEEDINGS

      The Company is not a party to any pending litigation and none is contemplated or threatened other than as described below:


ITEM 4. SUBMISSION OR MATTERS TO A VOTE OF SECURITY HOLDERS.

     No matters were submitted to a vote of shareholders in the year ending June 30, 2008.


PART II

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDERS MATTERS.

      The Company's securities are traded over-the-counter on the Bulletin Board operated by the National Association of Securities Dealers, Inc. under the symbol “FASC.” The table shows the high and low bid of the Company's Common Stock for the past two years:

      The Company’s shares of common stock are traded on the OTC Bulletin Board operated by the Financial Industry Regulatory Authority or FINRA under the symbol “FASC.”

 

-12-

 


 

      On June 28, 2008, the closing price of the Company’s common stock, as reported by the OTC Bulletin Board was $0.02. As of June 30, 2008, there were a total of 199,852,185 shares of common stock issued and outstanding. Of these shares, all are free trading with the exception of approximately 12,000,000 shares which may only be resold in compliance with Rule 144 of the Securities Act of 1933. As of June 30, 2008, the Company had 5,000 holders of record of its common stock.

      The following table sets forth the quarterly high and low bid prices per share for the Company’s common stock, as reported by the OTC Bulletin Board for the calendar years indicated. These quotations reflect inter-dealer prices, without retail mark-up, mark-down or commissions and may not represent actual transactions.

Quarter ended   High   Low  
2006      
                  Mar 31   0.032   0.031  
                  June 30   0.052   0.049  
                  September 30   0.05   0.043  
                  December 31   0.05   0.045  
2007      
                  March 31   0.016   0.018  
                  June 30   0.019   0.020  
                  September 30   0.04   0.043  
                  December 31   0.016   0.016  
2008      
                  March 31   0.017   0.018  
                  June 30   0.038   0.020  

Dividends

      The Company has not declared any cash dividends, nor does it intend to do so. The Company is not subject to any legal restrictions respecting the payment of dividends, except that dividends may not be paid to render the Company insolvent. Dividend policy will be based on the Company’s cash resources and needs and it is anticipated that all available cash will be needed for the Company’s operations in the foreseeable future.

Section 15(g ) of the Securities Exchange Act of 1934

      The Company’s shares are covered by Section 15(g) of the Securities Exchange Act of 1934, as amended that imposes additional sales practice requirements on broker/dealers who sell such securities to persons other than established customers and accredited investors (generally institutions with assets in excess of $5,000,000 or individuals with net worth in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with their spouses). For transactions covered by the Rule, the broker/dealer must make a special suitability determination for the purchase and have received the purchaser’s written agreement to the transaction prior to the sale. Consequently, the Rule may affect the ability of broker/dealers to sell our securities and also may affect your ability to sell your shares in the secondary market.

 

-13-

 


 

      Section 15(g) also imposes additional sales practice requirements on broker/dealers who sell penny securities. These rules require a one page summary of certain essential items. The items include the risk of investing in penny stocks in both public offerings and secondary marketing; terms important to in understanding of the function of the penny stock market, such as “bid” and “offer” quotes, a dealers “spread” and broker/dealer compensation; the broker/dealer compensation, the broker/dealers duties to its customers, including the disclosures required by any other penny stock disclosure rules; the customers rights and remedies in causes of fraud in penny stock transactions; and, the NASD’s toll free telephone number and the central number of the North American Administrators Association, for information on the disciplinary history of broker/dealers and their associated persons.

Securities authorized for issuance under equity compensation plans

      The Company currently has one equity compensation plan. Prior to 2000, the Company had three additional stock option plans. All shares which were authorized under those plans have been exhausted.

      The 2001 Incentive Stock Option Plan provides for the issuance of stock options for services rendered to the Company. The board of directors is vested with the power to determine the terms and conditions of the options. The Plan included 30,000,000 shares. To date options to purchase 30,000,000 shares have been granted and all options have been exercised, leaving no shares available for issuance under the Plan.

      The 2001A Incentive Stock Option Plan provides for the issuance of stock options for services rendered to the Company. The board of directors is vested with the power to determine the terms and conditions of the options. The Plan includes 20,000,000 shares. To date options to purchase 20,000,000 shares have been granted and all options have been exercised, leaving no shares available for issuance under the Plan.

      The 2003 Incentive Stock Option Plan provides for the issuance of stock options for services rendered to us. The board of directors is vested with the power to determine the terms and conditions of the options. The Plan includes 10,000,000 shares. To date options to purchase 10,000,000 shares have been granted and all options have been exercised, leaving no shares available for issuance under the Plan.

      The 2004 Incentive Stock Option Plan provides for the issuance of stock options for services rendered to us. The board of directors is vested with the power to determine the terms and conditions of the options. The Plan includes 10,000,000 shares. To date options to purchase 10,000,000 shares have been granted, leaving no shares available for issuance under the Plan.

      The 2005 Incentive Stock Option Plan provides for the issuance of stock options for services rendered to us. The board of directors is vested with the power to determine the terms and conditions of the options. The Plan includes 10,000,000 shares. At June 30, 2006, options to purchase 10,000,000 shares have been granted and exercised, leaving no shares available for issuance under the 2005 Plan.

 

-14-

 


 

          Number of securities  
    Number of securities to     Weighted-average   remaining available for future  
    be issued upon exercise     exercise price of   issuance under equity  
    of outstanding options,     outstanding options,   compensation plans  
    warrants and rights     warrants and rights   (excluding securities  
Plan category   (a)     (b)   in column (a)) (c)  
 
Equity compensation plans          
approved by security holders   None     None   None  
 
Equity compensation plans   10,000,000   $ 0.04   47,185  
not approved by securities holders          
 
Total     10,000,000   $ 0.04   47,185  


ITEM 6.
   SELECTED FINANCIAL DATA.
     

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.


ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

      The Information contained in this section reflects figures that are unaudited and may change subject to being audited.

We will amend this report upon receipt of audited financial statements.

      This section includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like: believe, expect, estimate, anticipate, intend, project and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements, which apply only as of the date of this prospectus. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or our predictions.

Liquidity and Capital Resources

      We were incorporated April 12, 1995 as a development stage company. We are the owner of the KDS disintegration technology which is patented in the USA, Canada, UK, Europe, Mexico, Australia, and New Zealand. In addition to the core patent, new patents for two new applications, one for the cryogenic freezing and shattering scrap rubber and one for separation of precious metals from mineral rock using our equipment have been granted. One other patent application for drying and recovery of fuel and clay from biomass has been submitted and is pending status. Further new registrations have been submitted in Japan, Malaysia and Korea. We have now reached commercial viability for several of our applications and have entered our marketing phase. To date, we have sold systems in Canada, the United States, Poland, Malaysia, South Korea, Japan, Mexico and the UK.

 

-15-

 


 

      On June 30, 2008, we had current assets of $ 140,644 and current liabilities of $ of 539,950 compared to the previous year on June 30, 2007 when we had $ 277,820 in current assets and $485,628 in current liabilities. Our working capital ratio on June 30, 2008 is negative for the second year in a row. The Company no long term debt other than amounts due to its Officers and Directors. The continued decline in working capital is putting strain on the Company’s ability to progress. We are currently talking to several different groups of private investors who have expressed interest to help raise some much needed capital.

Accounting issues

      Management believes that the carrying value of its technology licenses, patents and manufacturing rights are fairly stated at cost less amortization using the straight line method over 15 years based upon the estimated present value of cash flows and the Company’s projections to sell at least two machines each year through 2008. The Company exceeded this target in fiscal year 2007 and in 2008. Sales are booked when the equipment is delivered. We are currently holding deposits on two future sales for delivery in fiscal year 2009.

      In the year ended June 30, 2008 the Company adopted the equity method of accounting for its investment in the Malaysian joint venture and consequently has reduced the carrying value of that asset by its share of the accumulated losses incurred to date.

      Our auditors have issued a going concern statement because we do not have sufficient cash flow for us to maintain our operation for the next year. Consequently, our management will have to seek additional capital from new equity securities offerings, loans, or other fund raising activities to maintain our operation should new sales and receipt of receivables not materialize.

As of June 30, 2008 there were 199,852,195 shares issued and outstanding.

Results of Operations – Year ending June 03, 2008

      Revenue for the year ending June 30, 2008 was $795,165 . This is double sales of the previous year which were $364,959 Three machines were sold this year, and we are holding deposits on an additional two sales expected to be delivered in fiscal 2009. These sales will be booked when delivered as per our revenue recognition policy.

      Net losses for the year ended June 30, 2008 were $ 562,900 compared to a loss of $1,086,967 in the previous year. The Company’s audit have issued a going concern caution meaning we will need to increase sales or raise outside capital in under to continue operating at current levels

      The company anticipates future revenue to come from equipment sales, as well as its share in future profits from joint ventures, and by earning royalties and license fees under the following agreements. With the current orders in process, we will book 2 sales in the first part of fiscal year 2009 totaling approximately $500,000 USD.

 

-16-

 


 

Project Update

Japan - JP Steelplantech Co. License Agreement

      On September 26, 2005, the Company signed an exclusive license agreement for manufacturing and marketing the KDS System in Japan with JP Steelplantech Company of Yokohama, Japan. As part of the agreement JP Steel has paid an up front licensing fee and purchased and installed a fully operational KDS at its facility in Yokohama to be used for sales demonstrations and research purposes. Under the agreement, FASC will receive a royalty for each manufactured and machine sold in Japan. Marketing efforts are now underway, but there have been no sales yet to customers in Japan.

      JP Steel Plantech Co. is a well established engineering and equipment manufacturing company owned by four Japanese steel industry companies ; Kawasaki Heavy Industries (KHI), Hitachi Zosen (HITZ), JFE Engineering (JFE) and Sumitomo Heavy Industries (SHI).

      While he Japanese are diligently working with the equipment documenting every component of the system, they have yet to aggressively enter the marketing phase and have not sold any equipment to date. Nonetheless, we are encouraged by there work, and believe this will be very valuable to us over the long term. They are also working with our patent attorneys to finalize the examination process.

Korea - JNK Heaters Co. Ltd License Agreement

      This license was cancelled in April 2008 due to non-performance. We are now in negotiations with a new group who are interested in acquiring a licence for Korea under similar, but more stringent terms, as the previous licence.

Malaysia - FASCM Joint Venture & License Agreement

      On July 8, 2004, the Company granted an exclusive license for 21 years to First American Scinetific Corp (Malaysia) Bhd. Sdn., to market the KDS system in Malaysia, Thailand, Singapore and Indonesia. FASCM purchased one KDS machine and set up a fully operational demonstration plant in Malaysia. Under the agreement, FASC will receive a royalty for each machine manufactured and sold in the territory and will share 50 % in any excess profits from the operation. There was one sale in Malaysia to date, but the equipment was recovered when payment was not forthcoming. Two new projects are at the quotation stage.

      This is a very solid, well financed operation in which we hold a 50 % interest. The Malaysians are currently raising money privately to build a $ 1.3 million plant to process fibre which will be sold to China. Subsequent to the date of these statements, The joint venture received a firm order for 2 KDS Model MF-777 machines for delivery in 2009.

Brazil – Proposed Joint Venture & License Agreement

      On April 18, 2006, the Company announced the signing of an Agreement in Principle to form a joint venture to be named First American Scientific Brazil Ltda. These negotiations will not be finalized until the test machine sent to Brazil is fully operational and evaluated. The machine has been delivered, and subject to local permitting, is expected to be operational this calendar year.

 

-17-

 


 

Mexico

      In June we signed an exclusive marketing agreement with a group in Mexico. One condition was that they purchase a demonstration machine (at wholesale price) and adapt it to the local market and conditions. The machine has been delivered and is operational.

      The initial runs have all been successful, and the customer is now developing a unique food product which it advises it will launch later this calendar year.

Canada - Alternative Green Energy Systems Inc – Joint Venture

      This licence was cancelled in September 2008 for non-performance. We repossessed the test machine in AGES possession and returned it to our shop for evaluation and reconditioning. If salvageable, it will be returned to inventory.

Other material contracts:

Canada - City of Prince George, British Columbia

      FASC has signed a Memorandum of Understanding with the City of Prince George, British Columbia, Canada to assist them at their Waste Water Treament Plant in solving their environmental cleanup process of sewage sludge using the KDS Micronex System. This will be the first operation of its kind in the worls where strictly regulated Class B municipal sludge can be cleaned, bagged, and profitably sold to the public as a soil amendment. The initial runs are being monitored and evaluated by the University of BC, and if acceptable, the City will establish a permanent facility utilizing up to four KDS machines. To date all trial runs have been satisfactory, and after making many modifications, we have reached the Phase I goal of “proof of concept“ as reported by Dayton & Knight P.Eng.’s the City’s project engineers.

      Phase Two is underway at our Abbotsford site where some design changes and modifications are being made to handle the much wetter municipal sewage sludge.

Results will be announced as they materialize.

Waste Resources Action Program – UK

      This project is complete and the findings are being incorporated in our new designs at our Abbotsford test site.

Continuing Research and Development

      We continue to focus on improving the KDS equipment’s processing capacity and improve efficiencies for several different applications. We have determined that processing of softer materials such as biomass and pulp sludge currently represent the highest and best use for our technology and the most probable to generate sales. A fully equipped demonstration facility is being set up in Abbotsford, Canada, to perfect the sludge application and improve the KDS machine drying capabilities.

 

-18-

 


 

Inflation

      Inflation has not been a factor effecting current operations, and is not expected to have any material effect on operations in the near future.

Foreign Operations

      We rent office space in West Vancouver, British Columbia, Canada which serves as an administrative office and rent a sales office in Delta, British Columbia, and our demonstration facility is nearby in Abbotsford, British Columbia.

Trends

      Sales efforts are beginning to bring results with one machine being sold per quarter on average. Based upon three recent sales for next quarter, we anticipate revenue of $ 1,000,000 to $2,000,000 next fiscal year .

Recent Accounting Pronouncements

      In February 2007, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities –Including an amendment of FASB Statement No. 115” (hereinafter “SFAS No. 159”). This statement permits entities to choose to measure many financial instruments and certain other items at fair value. The objective is to improve financial reporting by providing entities with the opportunity to mitigate volatility in reported earnings cause by measuring related assets and liabilities differently without having to apply complex hedge accounting provisions. This Statement is expected to expand the use of fair value measurement, which is consistent with the Board’s long-term measurement objectives for accounting for financial instruments. This statement is effective as of the beginning of an entity’s first fiscal year that begins after November 15, 2007, although earlier adoption is permitted. Management has not determined the effect that adopting this statement would have on the Company’s financial condition for results of operations.

      In September 2006, the FASB issued SFAS No. 158, "Employers' Accounting for Defined Benefit Pension and Other Postretirement Plans ! An amendment of FASB Statements No. 87, 88, 106, and 132(R)." One objective of this standard is to make it easier for investors, employees, retirees and other parties to understand and assess an employer's financial position and its ability to fulfill the obligations under its benefit plans. SFAS No. 158 requires employers to fully recognize in their financial statements the obligations associated with single ! employer defined benefit pension plans, retiree healthcare plans, and other postretirement plans. SFAS No. 158 requires an employer to fully recognize in its statement of financial position the over funded or under funded status of a defined benefit postretirement plan (other than a multiemployer plan) as an asset or liability and to recognize changes in that funded status in the year in which the changes occur through comprehensive income. This statement also requires an employer to measure the funded status of a plan as of the date of its year-end statement of financial position, with limited exceptions. SFAS No. 158 requires an entity to recognize as a component of other comprehensive income, net of tax, the gains or losses and prior service costs or credits that arise during the period but are not recognized as components of net periodic benefit cost pursuant to SFAS No. 87. This statement requires an entity to disclose in the notes to financial statements additional information about certain effects on net periodic benefit cost for the next fiscal year that arise from

 

-19-

 


 

delayed recognition of the gains or losses, prior service costs or credits, and transition asset or obligation. Companies are required to initially recognize the funded status of a defined benefit postretirement plan and to provide the required disclosures for fiscal years ending after December 15, 2006. Management believes that this statement will not have a significant impact on the Company’s financial statements.

      In September 2006, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 157, “Fair Value Measurements” which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. Where applicable, SFAS No. 157 simplifies and codifies related guidance within GAAP and does not require any new fair value measurements. SFAS No. 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. Earlier adoption is encouraged. The Company does not expect the adoption of SFAS No. 157 to have a significant effect on its financial position or results of operation.

      In June 2006, the Financial Accounting Standards Board issued FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes – an interpretation of FASB Statement No. 109”, which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. FIN 48 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. FIN 48 is effective for fiscal years beginning after December 15, 2006. The Company does not expect the adoption of FIN 48 to have a material impact on its financial reporting, and the Company is currently evaluating the impact, if any, the adoption of FIN 48 will have on its disclosure requirements.


ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

      We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.


ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

       The financial statements filed herewith are unaudited. We are unable to obtain audited financial statements at this time. Accordingly, the foregoing financial statements are subject to change upon being audited by our auditors.

     We will amend this report upon receipt of audited financial statements.  

Table of Contents
Financial Statements  
Unaudited Consolidated Balance Sheets   F -2  
Unaudited Consolidated Statements of Operations and Comprehensive Income  Loss F -3  
Unaudited Consolidated Statement of Stockholders’ Equity   F -4  
Unaudited Consolidated Statements of Cash Flows   F -5  
Unaudited Notes to Consolidated Financial Statements   F -6  

 

-20-

 


 
FIRST AMERICAN SCIENTIFIC CORP.            
UNAUDITED CONSOLIDATED BALANCE SHEETS            
      June 30   June 30  
      2008   2007  
      Unaudited   Unaudited  
ASSETS              
 
CURRENT ASSETS              
   Cash     $   6,901 $   58,321  
   Accounts receivable, net of allowance       80,282   19,053  
   Sales tax refunds       23,552   24,222  
   Prepaid expenses       967   399  
   Inventory       28,942   175,826  
         T OTAL CURRENT ASSETS       140,644   277,821  
 
PROPERTY AND EQUIPMENT              
   Property and equipment       236,383   148,271  
   Less: accumulated depreciation       (128,243 )   (88,948 )  
          TOTAL PROPERTY AND EQUIPMENT       108,140   59,323  
 
OTHER ASSETS              
   Technology rights, net of amortization       517,742   644,742  
   Patents and manufacturing rights, net of amortization     87,695   105,877  
   Investments in joint ventures       126,543   263,158  
 
          TOTAL OTHER ASSETS       731,980   1,013,777  
 
TOTAL ASSETS     $   980,764 $   1,350,921  
 
LIABILITIES AND STOCKHOLDERS' EQUITY            
 
CURRENT LIABILITIES              
    Accounts payable and accrued expenses     $   163,987 $   229,364  
    Loans and wages payable to related parties       358,910   563,990  
    Deposits on Future Sales       375,963   256,264  
          TOTAL CURRENT LIABILITIES       898,860   1,049,618  
 
LONG-TERM LIABILITIES              
   Loans and wages payable to related parties       450,000   150,000  
          TOTAL LONG-TERM LIABILITIES       450,000   150,000  
 
COMMITMENTS AND CONTINGENCIES       -   -  
 
STOCKHOLDERS' EQUITY              
   Common stock - $.001 par value,              
     200,000,000 shares authorized; 199,852,195            
     196,143,955 shares issued and outstanding, respectively     199,852   196,144  
   Stock Options       287,291   287,291  
   Additional paid-in capital       12,965,445   12,902,005  
 
   Accumulated deficit       (13,780,613 )   (13,217,713 )  
   Accumulated other comprehensive (gain) loss       (40,072 )   (16,425 )  
 
          TOTAL STOCKHOLDERS' EQUITY       (368,096 )   151,303  
 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY   $   980,764 $   1,350,921  

 

The accompanying notes are an integral part of these unaudited financial statements.

F-2

 

-21-

 


 

FIRST AMERICAN SCIENTIFIC CORP.            
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS            
AND COMPREHENSIVE INCOME (LOSS)            
    Twelve months ended  
  June 30  
    2008   2007  
    Unaudited   Unaudited  
 
REVENUES            
      Revenues from equipment and machine sales   $ 772,165 $   323,560  
      Expenses recovered     23,569   41,399  
              Total Revenue     795,734   364,959  
 
COST OF SALES     428,893   232,739  
 
GROSS PROFIT     366,840   132,219  
 
OPERATING EXPENSES            
        -  
      Advertising     55,830   25,628  
      Amortization and depreciation     182,411   166,969  
      Consulting     32,673   74,011  
      Marketing     14,011   10,529  
      Professional services     91,943   109,763  
      Wages     352,673   454,306  
      Commissions     24,006   46,346  
      Research and development     4,738   33,171  
      General and administration     126,859   219,340  
      Bad debt expense     911   49,365  
      Rent     25,841   29,760  
              Total Operating Expenses     911,896   1,219,187  
 
LOSS FROM OPERATIONS     (545,054 )   (1,086,968 )  
 
OTHER INCOME (EXPENSE)            
 
      Deposits forfeited     118,764   -  
      Interest Income     5   -  
      Loss from change in accounting for Investment in joint venture     (136,615 )      
              Total Other Income (Expense)     (17,846 )   -  
 
LOSS BEFORE INCOME TAXES     (562,900 )   (1,086,967 )  
 
INCOME TAXES     -   -  
 
NET LOSS     (562,900 )   (1,086,967 )  
 
OTHER COMPREHENSIVE INCOME (LOSS)            
 
      Foreign Exchange Comprehensive Income     (23,647 ) 7,255  
 
COMPREHENSIVE NET LOSS   $ (586,547 )  $   (1,079,712 )  
 
      NET LOSS PER COMMON SHARE,            
              BASIC AND DILUTED   nil    $ nil  
 
      WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING,            
              BASIC AND DILUTED     197,477,537   193,187,705  

 


 

The accompanying notes are an integral part of these unaudited financial statements.

F-3

-22-

 


 

FIRST AMERICAN SCIENTIFIC CORP.                              
UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY              
            Additional               Other       Total  
          Common Stock   Paid -in     Stock     Accumulated     Comprehensive     Stockholders'  
      Shares   Amount       Capital     Options     Deficit     Income (Loss)     Equity  
  Balance, June 30, 2006   189,843,955   189,844     12,726,405     287,291     (12,130,745 )     (23,681 )     1,049,114  
 
  Common stock issued for Accounting   1,354,000   1,354     24,758                     26,112  
  1,000,000 shares @ $0.13737                                  
  354,000 shares @ $0.035                                  
  Common stock issued for Advertising   750,000   750     24,750                     25,500  
  750,000 shares @ $0.034                                  
  Common stock issued for Consulting   1,350,000   1,350     23,900                     25,250  
  850,000 shares @ $0.015                                  
  500,000 shares @ $0.025                                  
  Common stock issued for Legal Fees   500,000   500     13,038                     13,538  
  500,000 shares @ $0.032                                  
  Common stock issued for Rent   471,000   471     16,029                     16,500  
  471,000 shares @ $0.035                                  
  Common stock issued for Salaries   1,875,000   1,875     73,125                     75,000  
  1,875,000 shares @ $0.004                                  
  Foreign currency translation gain                         7,255     7,255  
  Net Income for the period ended June                                  
  30, 2007                   (1,086,968 )           (1,086,968 )  
Balance, June 30, 2007   196,143,955   196,144   $ 12,902,005   $ 287,291   $ (13,217,713 )   $ (16,426 )   $   151,301  
  Common stock issued for Marketing                                  
  1,500,000 shares @ $0.018   1,500,000   1,500     25,500                     27,000  
  Common stock issued for Rent                                  
  1,000,000 shares @ $0.0183   1,000,000   1,000     17,333                     18,333  
  Common stock issued for Website                                  
  Development 868,240 shares @ $0.017   1,033,240   1,033         16,532                     17,565  
  Common stock issued for Website                                  
  Development 25,000 shares @ $0.02   25,000   25     475                     500  
  Common stock issued for Website                                  
  Development 150,000 shares @ $0.025   150,000   150     3,600                     3,750  
  Foreign currency translation gain                         (23,646 )     (23,646 )  
  Net Income for the period ended June                                  
  30, 2008                   (562,900 )           (562,900 )  
Balance, June 30, 2008   199,852,195   199,852     12,965,445     287,291     (13,780,613 )     (40,072 )     (368,097 )  

The accompanying notes are an integral part of these unaudited financial statements.

F-4

 

-23-

 


 

FIRST AMERICAN SCIENTIFIC CORP.                
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS                
    Twelve months ended  
    June 30,  
    2007     2008  
    Unaudited     Unaudited  
CASH FLOWS FROM OPERATING ACTIVITIES            
      Net loss   $ (426,285 )   $   (1,086,967 )  
 
      Depreciation and amortization     184,477     166,969  
      Bad debt expense     911        
      Stock and options issued for services and compensation     48,815     181,900  
      Stock issued for rent     18,333        
      Stock issued for commissions     -        
 
      Options issued for compensation     -        
 
      Income for licensing fees on Malaysia joint venture     -        
              paid with stock in joint venture company     -        
      Adjustments to reconcile net loss to net cash            
              used by operations:            
              Decrease (increase) in accounts receivable     (37,763 )     383,358  
              Decrease(increase) in allowance for bad bebt     (24,375 )        
              Decrease (increase) in taxes and tax credits     669     (16,514 )  
              Decrease (increase) in inventory     146,884     (15,633 )  
              Decrease (increase) in deposits and prepaid expenses     (568 )     199,478  
              Decrease (increase) in deposits held     119,698        
              Increase (decrease) in accounts payable & accrued expenses     (65,376 )     (34 )  
              Increase (decrease) in payable to related parties         271,648  
Net cash provided (used) by operating activities     (34,581 )     84,205  
 
CASH FLOWS FROM INVESTING ACTIVITIES            
              Purchase of equipment     (88,112 )        
              Investments     -     0  
              Investment in technology rights and patents     -     0  
Net cash provided (used) in investing activities     (88,112 )     0  
 
CASH FLOWS FROM FINANCING ACTIVITIES            
              Proceeds from borrowing     -     0  
              Net proceeds from borrowing, related parties     94,920     (37,973 )  
              Proceeds from sales of stock            
Net cash used by financing activities     94,920     (37,973 )  
 
NET INCREASE (DECREASE) IN CASH     (27,773 )     46,231  
 
Other comprehensive gain (loss) - foreign currency translation     (23,647 )     7,655  
 
CASH - Beginning of period     58,321     4,436  
 
CASH - End of period   $ 6,901   $   58,321  
 
SUPPLEMENTAL CASH FLOW DISCLOSURES:            
      Interest expense   -   $   -  
      Income taxes   $   -   $   -  
 
NON-CASH FINANCING AND INVESTING TRANSACTIONS:            
      Common stock issued for services and compensation         54,288  
 
      Common stock issued for services and current debt            
      Common stock issued for expenses     48,815        
      Options issued for compensation         75,000  
      Stock issued for professional fees         26,112  
      Stock issued for rent and expenses     18,333     16,500  
      Stock issued for services and consulting         0  

 

The accompanying notes are an integral part of these unaudited financial statements.

F-5

-24-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

_________________________________________________________________________________________________________________________

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

First American Scientific Corp. (hereinafter “the Company” or “FASC”) was incorporated in April 1995 under the laws of the State of Nevada primarily for the purpose of manufacturing and operating equipment referred to as the KDS Micronex System. This patented process has the capability of reducing industrial material such as limestone, gypsum, zeolite, wood chips, bio-waste, rubber and ore containing precious metals to a fine talcum-like powder. The process can significantly increase the end value of the host material. The Company maintains an office in West Vancouver, British Columbia, Canada and a demonstration and sales site in Abbotsford, British Columbia, Canada. The Company’s year-end is June 30 th .

First American Scientific (Canada) Ltd. – wholly owned subsidiary

The Company formed First American Scientific (Canada) Ltd., formerly named First American Power Corp., and 521345 BC Ltd., a 100 % wholly owned subsidiary, in 1998 in order to provide research and development services eligible for Canadian research and development credits exclusively to FASC and, when feasible, to operate a profitable production facility in Canada.

First American Scientific Corp ( Malaysia ) Bhd. Sdn, - joint venture

On July 8, 2004, the Company entered into a joint venture agreement with two Malaysian companies to sell and market the KDS Micronex Machine. Under the terms of the agreement, the joint venture ordered one KDS Micronex Machine from FASC and set up a demonstration plant in Malaysia for the KDS System utilizing the KDS Micronex Machine acquired from the Company. In September of 2005, the Company sold a license agreement to FASC Bhd. Sd. for 50 % of the outstanding shares of common stock of the joint venture.

The Company accounts for this investment in accordance with APB 18 at cost. FASC does not participate in or influence operating or financial decisions of the joint venture. The investment is valued at the agreed upon purchase price of the 21 year license for the KDS technology.

Alternative Green Energy Systems, Inc. - Licensee

The Company formed Alternative Green Energy Systems, Inc. (hereinafter “AGES”) in 2002 for the purpose of using FASC’s licensed technology and patents to manufacture, sell, operate and use KDS machines in combination with available expertise in wood dust burning technology. In 2002 and 2003, the Company reported financial information from AGES on a consolidated basis due to its control of AGES.

In September 2005, AGES issued a cash call to all its shareholders. In October 2005, AGES received $ 700,000 Cdn in new funding from its other shareholders. FASC did not participate in the September cash call and its shareholdings in AGES were diluted to 12 %. In June 2007, Hydro Quebec exercised its put option and forced the sale of 100% AGES to a third party for one dollar plus the assumption of AGES debts. Being unwilling to assume AGES debts which exceeded $ 1.200,000 Cdn, FASC‘s shareholdings were purged, and a new group has now taken over 100 % control of AGES.

 

F-6

-25-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________


The debt that was due to FASC by AGES has not been paid and FASC is in a position to cancel the license.

JP Steelplantech Company (Japan) - Licensee

On September 26, 2005, the Company signed an exclusive license agreement for manufacturing and marketing the KDS System in Japan with JP Steelplantech Company of Yokohama, Japan. As part of the agreement JP Steel has paid an up front licensing fee and purchased and installed a fully operational KDS at its facility in Yokohama to be used for sales demonstrations and research purposes. JP Steel must also pay a royalty to FASC for each machine manufactured and sold in Japan.

JNK Heaters Co. Ltd ( Korea ) - Licensee

On December 14, 2005, the Company signed an exclusive license agreement for the marketing of the KDS System in Korea with JNK Heaters Co. Ltd of Seoul, Korea. As part of the agreement JNK has paid an up front deposit for a licensing fee and machine purchase, and finalized the purchase and installation of a fully operational KDS at its facility in Seoul within one year. The License allows JNK to earn the right to manufacture machines in Korea after meeting certain contractual conditions. These conditions have yet to be met. JNK would also pay a royalty for each machine manufactured and sold in Korea.

Waste and Resources Action Programme – Research project - United Kingdom

In September 2004, we signed an agreement wherein WRAP has agreed to provide funding to develop “value enhanced end-products” from the output of the KDS machine. WRAP has agreed to provide $1,000,000 USD for the purchase and installation of one complete KDS system to be located at a local pulp & paper mill in England. The fund will also pay for market research, scientific research, re-design and adaptation costs for the equipment and supplementary systems for industry-specific applications over an 18 month period. The goals of the project are to demonstrate the KDS technology in a working environment, optimize ancillary equipment to improve its efficiency, and identify markets for recycled end products. In Dec 2004, a KDS Model S-4 was shipped to Aylesford Newsprint in London, England for trial runs and evaluation. The initial testing phase is now complete and the results published in the WRAP report released in late April 2007 indicate the process is scientifically sound, is commercially viable in several areas, but needs more development work prior to implementation

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

This summary of significant accounting policies of FASC is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Accounting Method

The Company uses the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.

 

F-7

-26-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________

Accounts Receivable

The Company carries its accounts receivable at cost less an allowance for doubtful accounts. At June 30, 2008, accounts receivable were $80,282 with no allowance for doubtful accounts required at the date of preparing these statements. At June 30, 2007 accounts receivable was $ 19,053

The Company’s policy is to accrue interest on trade receivables 30 days after invoice date. A receivable is considered past due if payments have not been received by the Company for 90 days. In 2008 the Company wrote off as a bad debt $ 910 of accounts receivable past due over 180 days and $ 48,465 in 2007. Any amounts collected at a later date will be included in income.

During the year ended June 30, 2008, the Company had $795,734 in revenue from the sale of three machines and related services.

Advertising Expenses

Advertising expenses consist primarily of costs incurred in the design, development, and printing of Company literature and marketing materials. The Company expenses all advertising expenditures as incurred. The Company's advertising expenses were $25,627 and $ 55,830 for the years ended June 30, 2007 and 2008, respectively.

Cash and Cash Equivalents

For purposes of its statement of cash flows, the Company considers all short-term debt securities purchased with a maturity of three months or less to be cash equivalents.

Compensated Absences

Employees of the Company are entitled, by Canadian law, for paid time off equal to four percent of their wages. At June 30, 2008, no amounts were accrued as all paid time off had be taken.

Comprehensive Income

In June 1997, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 130, "Reporting Comprehensive Income" (hereinafter "SFAS No. 130"). SFAS 130 establishes standards for reporting and displaying comprehensive income, its components and accumulated balances. SFAS No. 130 is effective for periods beginning after December 15, 1997. The Company adopted this accounting standard and its adoption is reflected in the accompanying financial statements.

Concentration of Risk

The Company maintains its Canadian cash accounts in primarily one commercial bank in Vancouver, British Columbia, Canada. Its U.S. dollars are maintained in a bank account in Vancouver, British Columbia, Canada.

All worldwide accounts receivable and sales are booked in US dollars, except Canadian sales and Canadian manufacturing costs which are booked in Canadian dollars.

 

F-8

-27-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________

Derivative Instruments

The Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities,” as amended by SFAS No. 137, “Accounting for Derivative Instruments and Hedging Activities – Deferral of the Effective Date of FASB No. 133”, and SFAS No. 138, “Accounting for Certain Derivative Instruments and Certain Hedging Activities” and SFAS No. 149, “Amendment of Statement 133 on Derivative Instruments and Hedging Activities”. These statements establish accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. They require that an entity recognize all derivatives as either assets or liabilities in the consolidated balance sheet and measure those instruments at fair value.

If certain conditions are met, a derivative may be specifically designated as a hedge, the objective of which is to match the timing of gain or loss recognition on the hedging derivative with the recognition of (i) the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk or (ii) the earnings effect of the hedged forecasted transaction. For a derivative not designated as a hedging instrument, the gain or loss is recognized in income in the period of change.

Historically, the Company has not entered into derivatives contracts to hedge existing risks or for speculative purposes.

At June 30, 2008, the Company has not engaged in any transactions that would be considered derivative instruments or hedging activities.

Fair Value of Financial Instruments

The carrying amounts for cash, accounts receivable, accounts payable, and accrued liabilities approximate their fair value.

Foreign Currency Translation

Assets and liabilities of the Company’s foreign operations are translated into U.S. dollars at the period-end exchange rates, and revenue and expenses are translated at the average exchange rates during the period. Exchange differences arising on translation are disclosed as a separate component of shareholders’ equity. Realized gains and losses from foreign currency transactions are reflected in the Company’s results of operations.

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of the Company’s assets and the satisfaction of its liabilities in the normal course of operations.

As shown in the accompanying financial statements, the Company has incurred an accumulated deficit of $13,780,613 through June 30, 2008 and has limited cash resources. The Company recorded increased sales during the year ended June 30, 2008, but generated a net loss of $586,547. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

F-9

-28-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________

Management plans to substantially increase sales through current channels and develop new sales opportunities. Management has also established plans designed to increase the sales of the Company’s products by continued research and development and combining technology with its licensees in Canada, Japan, and Korea through its joint venture in Malayisa. Management intends to seek new capital from new equity securities offerings that will, if successful, provide funds needed to increase liquidity, fund internal growth and fully implement its business plan. However, there is no assurance that the Company will raise the required capital. If the Company is unable to raise the required capital, then it will assess its future business viability.

The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event the Company cannot continue in existence .

Impairment of Long-Lived Assets

In October 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets” (hereinafter “SFAS No. 144”). SFAS No. 144 replaces SFAS No. 121, “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed of.” This standard establishes a single accounting model for long-lived assets to be disposed of by sale, including discontinued operations. SFAS No. 144 requires that these long-lived assets be measured at the lower of carrying amount or fair value less cost to sell, whether reported in continuing operations or discontinued operations. This statement is effective beginning for fiscal years after December 15, 2001.

In complying with this standard, the Company reviews its long-lived assets quarterly to determine if any events or changes in circumstances have transpired which indicate that the carrying value of its assets may not be recoverable. The Company determines impairment by comparing the present value of future cash flows estimated to be generated by its assets to their respective carrying amounts. As of June 30, 2007, no impairments were deemed necessary.

Inventory

In November 2004, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards No. 151, “Inventory Costs— an amendment of ARB No. 43, Chapter 4”. This statement amends the guidance in ARB No. 43, Chapter 4, “Inventory Pricing,” to clarify the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material (spoilage). Paragraph 5 of ARB 43, Chapter 4, previously stated that “. . . under some circumstances, items such as idle facility expense, excessive spoilage, double freight, and rehandling costs may be so abnormal as to require treatment as current period charges. . . .” This statement requires that those items be recognized as current-period charges regardless of whether they meet the criterion of “so abnormal.” In addition, this statement requires that allocation of fixed production overheads to the costs of conversion be based on the normal capacity of the production facilities. This statement is effective for inventory costs incurred during fiscal years beginning after June 15, 2005. Management does not believe the adoption of this statement will have any immediate material impact on the Company.

 

F-10

-29-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________

Inventories are stated at the lower of average cost or net realizable value. The cost of finished goods includes the cost of raw material, direct and indirect labor and other indirect manufacturing costs.

One machine sold during the year ended June 30, 2007 and three were sold in 2008.

Net Loss Per Share

In June 1999, the Company adopted Statement of Financial Accounting Standards Statement No. 128, “Earnings Per Share.” Basic earnings (net loss) per share is computed using the weighted average number of common shares outstanding. Diluted net loss per share for FASC is the same as basic net loss per share, as the inclusion of common stock equivalents would be antidilutive.

Prepaid Expenses

At of June 30, 2008 and June 30, 2007, prepaid expenses consist of a refundable utility deposit.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant inter-company transactions and balances have been eliminated in consolidation.

FASC consolidates its financial statements with First American Scientific (Canada) Ltd as it is a wholly owned and controlled by FASC.

Historically, FASC has owned 40% of the outstanding shares of AGES, as well ownership of all AGES technology. AGES's license to use the technology was conditional upon it meeting certain conditions. Because, as of June 30, 2003, these conditions had not been met, FASC was deemed to be in a position of control and AGES was treated as a majority owned subsidiary of FASC with its financial statements consolidated with FASC.

During the year ended June 30, 2005, the agreement between FASC and AGES was renegotiated. Under the new agreement, FASC owns 12 % of AGES. As a consequence, FASC has no control over AGES and will in this and future financial statements report its investment in AGES using the equity method. Its investment in AGES has been offset against net losses generated by AGES. See Note 9. As of June 30, 2007, the Company had no shareholdings in AGES.

Prior to 2007, the Company accounted for its investment in the joint venture with FASC Malaysia accordance with APB 18 at cost. FASC does not participate in or influence operating or financial decisions of the joint venture. The investment was valued at the agreed upon purchase price of the 21 year license for the KDS technology. Due to the passage of time, in the year ending June 30, 2008 the Company changed its method of accounting for its investment in the Malaysian joint venture to the equity method. Consequently, the carrying value of the asset has been reduced by its share of the accumulated losses incurred to date.

 

F-11

-30-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________

Provision for Taxes

Income taxes are provided based upon the liability method of accounting pursuant to Statement of Financial Accounting Standards No. 109, “Accounting for Income Taxes” (hereinafter “SFAS No. 109”). Under this approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded against deferred tax assets if management does not believe the Company has met the “more likely than not” standard imposed by SFAS No. 109 to allow recognition of such an asset.

At June 30, 2006, the Company had net deferred tax assets of approximately $2,500,000 principally arising from net operating loss carryforwards, at an expected rate of 34%, for income tax purposes. As management of the Company cannot determine that it is more likely than not that the Company will realize the benefit of the net deferred tax asset, a valuation allowance equal to the net deferred tax asset has been established at June 30, 2005. The change in the deferred tax asset valuation allowance from June 30, 2007 to June 30, 2008 was $500,000 bringing the net value of the deferred tax asset to zero.

The significant components of the deferred tax asset at June 30, 2008 and June 30, 2007 were as follows:

    June 30, 2008     June 30, 2007  
    Unaudited         Unaudited  
Net operating loss carryforward   $   13,780,613   $   13,217,713  
Stock options issued under a non-qualified plan:              
For the year ended June 30, 2007   $   -   $   -  
For the year ended June 30, 2008   $   -   $   -  
 
Deferred tax asset   $   3,000,000   $   3,000,000  
Deferred tax asset valuation allowance   $   (3,000,000 )   $   (2,500,000 )  

At June 30, 2008, the Company has net operating loss carryforwards of approximately $13,780,613 which expire in the years 2015 through 2025.

Recent Accounting Pronouncements

In December 2004, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 153 (hereinafter “SFAS No. 153”). This statement addresses the measurement of exchanges of nonmonetary assets. The guidance in APB Opinion No. 29, “Accounting for Nonmonetary Transactions,” is based on the principle that exchanges of nonmonetary assets should be measured based on the fair value of the assets exchanged. The guidance in that opinion, however, included certain exceptions to that principle. This statement amends Opinion 29 to eliminate the exception for nonmonetary exchanges of similar productive assets and replaces it with a general exception for exchanges of nonmonetary assets that do not have commercial substance. A nonmonetary exchange has commercial substance if the future cash flows of the entity are expected to change significantly as a result of the exchange. This statement is effective for financial statements for fiscal years beginning after June 15, 2005. Earlier application is permitted for nonmonetary asset exchanges incurred during fiscal years beginning after the date of this statement is issued. During the year ended June 30, 2005, the Company adobted SFAS No. 153. The Company has determined that there was no financial impact from the adoption of this statement.

 

F-12

-31-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________

In May 2003, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity” (hereinafter “SFAS No. 150”). SFAS No. 150 establishes standards for classifying and measuring certain financial instruments with characteristics of both liabilities and equity and requires that those instruments be classified as liabilities in statements of financial position. Previously, many of those instruments were classified as equity. SFAS No. 150 is effective for financial instruments entered into or modified after May 31, 2003 and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. The Company determined that there was no impact on the Company’s financial statements from the adoption of this statement.

Reclassifications

Certain prior year amounts in the accompanying financial statements have been reclassified to conform to the fiscal 2005 presentation. The reclassifications principally consists of reclassification of the fair market value of all outstanding options and warrants as paid-in-capital instead of a separate caption on the balance sheets and statement of stockholders’ equity. These reclassifications have resulted in no changes to the Company’s accumulated deficit or net losses presented. See Note 5 and 6.

Revenue and Cost Recognition

Revenues from the sale of KDS machines are recognized when there is a sales contract, all terms of the contract have been completed, collectibility is reasonably assured and the products are delivered.

KDS machine costs include applicable direct material and labor costs and related indirect costs. Changes in job performance, job conditions and estimated profitability may result in revisions to product costs, which are recognized in the period in which the revisions are determined.

Sales Tax Refunds-Goods and Services tax (GST)

The Canadian Government requires Canadian resident companies to collect sales taxes from customers when goods and services are sold in Canada. These taxes collected can be offset by taxes paid (tax credits) for goods and services purchased in Canada. Any sale outside of Canada is not taxed for this purpose. At the end of each quarter, all taxes paid on goods and services purchased are netted against the taxes due on sales of goods and services sold. Because the Company has more tax credits than taxes collected, as of June 30, 2008 the Company is due a refund of $23,552.

Use of Estimates

The process of preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions regarding certain types of assets, liabilities, revenues, and expenses. Such estimates primarily relate to unsettled transactions and events as of the date of the financial statements. Accordingly, upon settlement, actual results may differ from estimated amounts.

 

F-13

-32-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

___________________________________________________________________________________________________________________________

NOTE 3 – PROPERTY AND EQUIPMENT

In October 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 143, “Accounting for Asset Retirement Obligations” (hereinafter “SFAS No. 143”). SFAS No. 143 establishes guidelines related to the retirement of tangible long-lived assets of the Company and the associated retirement costs. This statement requires that the fair value of a liability for an asset retirement obligation be recognized in the period in which it is incurred, if a reasonable estimate of fair value can be made. The associated asset retirement costs are capitalized as part of the carrying amount of the long-lived assets. This statement is effective for financial statements issued for the fiscal years beginning after June 15, 2002. The Company adopted SFAS No. 143 and the adoption has not had a material impact on the financial statements of the Company.

In August 2001, the FASB issued Statement of Financial Accounting Standards No. 144 (hereinafter “SFAS No. 144”), “Accounting for the Impairment of Long-Lived Assets,” which requires a single accounting model to be used for long-lived assets to be sold and broadens the presentation of discontinued operations to include a “component of an entity” (rather than a segment of a business). A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. A component of an entity that is classified as held for sale, or has been disposed of, is presented as a discontinued operation if the operations and cash flows of the component will be (or have been) eliminated from the ongoing operations of the entity and the entity will not have any significant continuing involvement in the operations of the component. The Company adopted SFAS No. 144 effective August 1, 2001.

Property and equipment are stated at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the assets. The useful lives of property, plant and equipment for purposes of computing depreciation is five years.

The following is a summary of property, equipment, and accumulated depreciation:

    June 30,     June 30,  
    2007     2008  
    Unaudited     Unaudited  
 
Plant assets and equipment     148,271     236,383  
 
Total assets     148,271     236,383  
Less accumulated depreciation     (88,948 )   (128,243 )
  $   59,323   $   108,140  

 

F-14

-33-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________

Depreciation expense for the years ended June 30, 2007 and 2008 was $ 166,969 and $182,411 respectively. The Company evaluates the recoverability of property and equipment when events and circumstances indicate that such assets might be impaired.

The Company determines impairment by comparing the present value of future cashflows estimated to be generated by these assets to their respective carrying amounts. Maintenance and repairs are expensed as incurred. Replacements and betterments are capitalized. The cost and related reserves of assets sold or retired are removed from the accounts, and any resulting gain or loss is reflected in results of operations.

NOTE 4 – TECHNOLOGY RIGHTS AND PATENTS

Intangible Assets

In June 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 141, "Business Combinations" (hereinafter “SFAS No. 141”) and Statement of Financial Accounting Standards No. 142, "Goodwill and Other Intangible Assets" (hereinafter “SFAS No. 142”). SFAS No. 141 provides for the elimination of the pooling-of-interests method of accounting for business combinations with an acquisition date of July 1, 2001 or later. SFAS No. 142 prohibits the amortization of goodwill and other intangible assets with indefinite lives and requires periodic reassessment of the underlying value of such assets for impairment. SFAS No. 142 is effective for fiscal years beginning after December 15, 2001. On June 30, 2001, the Company adopted SFAS No. 142. Application of the nonamortization provision of SFAS No. 142 resulted in no change to reported earnings in the years ended June 30, 2005 and June 30, 2004, as the Company does not have recorded assets with indeterminate lives.

Technology Licenses

On June 22, 1995, the Company entered into a license agreement with Spectrasonic Corp. (hereinafter "Spectrasonic"), a related party, for the worldwide license to its unpatented Kinetic Disintegration Equipment (“KDS”) for use in rubber and glass recycling and disposal, for a period of ninety-nine years. The purchase price of this license and one SDM machine was $550,000, with license rights valued at $250,000.

On February 22, 1996, the Company entered into an additional license agreement with Spectrasonic for the worldwide license to its unpatented Ultrasound Equipment for exclusive use in gypsum disintegration, disposal, recycling, remanufacturing or manufacturing of used or new raw materials. The purchase price of this license and one KDS machine for gypsum-related use was $775,000, with the parties agreeing that the technology license was valued at $425,000 and the gypsum KDS machine was valued at $350,000.

On May 17, 1996, the Company executed another agreement with Spectrasonic for the worldwide licenses to equipment (as yet unpatented) developed by Spectrasonic for use in disintegration, disposal, recycling, remanufacturing or manufacturing "any and all kinds of materials" for a period of ninety-nine years. The purchase price of this license was $1,047,000, which the Company paid by issuing to Spectrasonic 5,500,000 shares of First American common stock (with an aggregate deemed value of $802,000) and paying $168,000 in varying installment amounts between September 30, 1996 and January 2, 1997. The Company also recognized $77,000 in forgiveness of debt, which was recorded as additional paid-in capital.

 

F-15

-34-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________

On July 2, 1997, the Company finalized negotiations with Spectrasonic for all patents to be issued or pending, including all data pertaining to the patent process with respect to the Kinetic Disintegration Machine (“KDS Machine”), whose worldwide rights had been previously acquired by the Company. In the negotiations, the Company acquired all manufacturing rights applicable to the KDS Machine technology. The Company has sole right and responsibility for manufacturing the machinery. Consideration to Spectrasonic was 1,000,000 common shares of the Company’s stock at a deemed value of $0.25 per share issued on December 1, 1999.

Technology licenses, patents and manufacturing rights are stated at cost. Amortization is provided using the straight-line method over the estimated useful lives of the assets, which is fifteen years.

The following is a summary of technology licenses, patents and manufacturing rights and accumulated amortization:

    June 30,     June 30,    
    2008     2007    
    Unaudited     Unaudited    
      Technology licenses and rights   $   1,905,000   $   1,905,000    
      Patents and manufacturing rights   272,727     272,699    
    2,177,727     2,177,699    
      Less accumulated amortization     (1,572,289 )     (1,427,107 )    
  $   605,438   $   750,592    

Amortization expense for the year ended June 30, 2008 and 2007 was $ 145,154 and $145,182 respectively.

The Company has determined that the carrying value of its technology rights and patents is fairly stated, based upon the estimated present value of cash flows and the Company’s estimated ability to sell two machines each year through the year ended June 30, 2006. The following is a summary of the costs of patents approved.

        Accumulated        
    Cost     Amortization     Net Amount  
Balance, June 30, 2006     272,727     (148,668 )     124,059  
2007 Activity     -     (18,182 )     (18,182 )  
Balance, June 30, 2007   $   272,727   $   (166,850 )   $   105,877  
2008 Activity     -     (18,182 )     (18,182 )  
Balance, June 30, 2007   $   272,727   $   (185,032 )   $   87,695  

 

F-16

-35-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

_________________________________________________________________________________________________________________________

NOTE 5 – COMMON STOCK

Stock Based Compensation

In December 2004, the Financial Accounting Standards Board issued a revision to Statement of Financial Accounting Standards No. 123R, “Accounting for Stock Based Compensations.” This statement supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and its related implementation guidance. This statement establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. This statement focuses primarily on accounting for transactions in which an entity obtains employee services in share-based payment transactions. This statement does not change the accounting guidance for share based payment transactions with parties other than employees provided in Statement of Financial Accounting Standards No. 123. This statement does not address the accounting for employee share ownership plans, which are subject to AICPA Statement of Position 93-6, “Employers’ Accounting for Employee Stock Ownership Plans.” The Company has not yet determined the impact to its financial statements from the adoption of this statement.

Statement of Financial Accounting Standards No. 123, “Accounting for Stock-Based Compensation” , defines a fair value-based method of accounting for stock options and other equity instruments. The Company has adopted this method, which measures compensation costs based on the estimated fair value of the award and recognizes that cost over the service period.

In December 2002, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 148, “Accounting for Stock-Based Compensation – Transition and Disclosure” (hereinafter “SFAS No. 148”). SFAS No. 148 amends SFAS No. 123, “Accounting for Stock-Based Compensation,” to provide alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. In addition, the statement amends the disclosure requirements of SFAS No. 123 to require prominent disclosure in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results. The provisions of the statement effective for financial statements for fiscal years ending after December 15, 2002 are not expected to impact the Company’s financial statements. The Company currently reports stock issued to employees under the rules of SFAS No. 123. Accordingly, there is no change in disclosure requirements due to SFAS No. 148.

During the year ended June 30, 2008, the Company issued 3,708,240 shares of stock as follows: 1,000,000 shares of common stock as rent with a fair market value of $ 18,333 and 2,708,240 shares of common stock in payment of website development with a fair market value of $51,963.

 

F-17

-36-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________

During the year ended June 30, 2007, the Company issued 6,300,000 shares of stock as follows: 1,875,000 shares of common stock as payment for management salaries with a fair market value of $ 75,000; 471,000 shares of common stock in payment of rent with a fair market value of $ 16,500, 1,354,000 shares of common stock in payment of accounting with a fair market value of $ 26,112, 500,000 shares of common stock in payment of legal fees with a fair market value of $ 16,000, 750,000 shares of common stock in payment of advertising with a fair market value of $ 25,000, 1,350,000 shares of common stock in payment of consulting fees with a fair market value of $ 25,250.

During the year ended June 30, 2006, the Company issued 8,400,000 shares of stock as follows: 7,850,000 shares of common stock as payment for services with a fair market value of $314,000; 550,000 shares of common stock in payment of rent with a fair market value of $ 22,000.

NOTE 6 – STOCK OPTIONS

The Company’s board of directors approved the First American Scientific Corp. 2005 Non-qualified Stock Option Plan. This plan allows the Company to distribute up to 10,000,000 shares of common stock options at a maximum share price of $0.04 to persons employed or associated with the Company. This plan was not approved by the Company’s security holders.

The Company’s board of directors approved the First American Scientific Corp. 2006 Non-qualified Stock Option Plan. This plan allows the Company to distribute up to 5,000,000 shares of common stock options at a maximum share price of $0.04 to persons employed or associated with the Company. This plan was not approved by the Company’s security holders.

During the year ended June 30, 2005, the Company granted 11,740,000 options of which all were immediately exercised.

During the year ended June 30, 2006, the Company granted 8,016,000 options of which 5,925,000 have not been exercised.

During the year ended June 30, 2007, the Company granted 6,300,000 options of which all have been exercised.

During the year ended June 30, 2008, the Company granted 3,708,240 options of which all have been exercised

The fair value of each option granted during the year ended June 30, 2006 was estimated on the grant date using the Black-Scholes Option Price Calculation. The following assumptions were made in estimating fair value: risk-free interest of 5%, volatility of 71%, expected life of 1 to 5 years, and no expected dividends. The additional value assigned to these options granted during the year ended June 30, 2006 is $33,000.

 

F-18

-37-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________

The fair value of each option granted during the year ended June 30, 2005 was estimated on the grant date using the Black-Scholes Option Price Calculation. The following assumptions were made in estimating fair value: risk-free interest of 5%, volatility of 71%, expected life of 1 to 5 years, and no expected dividends. There was no additional value assigned to these options granted during the year ended June 30, 2005 because all options granted were immediately exercised.

The Company’s board of directors approved the First American Scientific Corp. 2004 and 2004A Non-qualified Stock Option Plan. This plan allows the Company to distribute up to 20,000,000 shares of common stock options at a maximum share price of $0.05 to persons employed or associated with the Company. This plan was not approved by the Company’s security holders.

During the year ended June 30, 2004, the Company granted 19,918,600 options of which 16,918,600 were immediately exercised. The remaining 3,000,000 stock options were granted at the fair market value of the common stock at the date of grant. These options were granted for compensation, services and operating expenses at the average exercise price of $0.05.

The fair value of each option granted during the year ended June 30, 2004 was estimated on the grant date using the Black-Scholes Option Price Calculation. The following assumptions were made in estimating fair value: risk-free interest of 5%, volatility of 71%, expected life of 1 to 5 years, and no expected dividends. The value of these options granted during the year ended June 30, 2004 in the amount of $83,060 was included in operating expense in the financial statements.

The Company’s board of directors approved the First American Scientific Corp. 2003 Non-qualified Stock Option Plan. This plan allows the Company to distribute up to 10,000,000 shares of common stock options at a maximum share price of $0.075 to persons employed or associated with the Company. This plan was not approved by the Company’s security holders.

During the year ended June 30, 2003, the Company granted 13,130,249 common stock options at the fair market value of the common stock at the date of grant. These options were granted for compensation, services and operating expenses at the average exercise price of $0.05.

The fair value of each option granted during the year ended June 30, 2003 was estimated on the grant date using the Black-Scholes Option Price Calculation. The following assumptions were made in estimating fair value: risk-free interest of 4%, volatility of 73%, expected life of 1 to 5 years, and no expected dividends. The value of these options granted during the year ended June 30, 2003 in the amount of $56,870 was included in operating expense in the financial statements.

There is no express termination date for the options, authorized by the Company’s plans, although the Company’s board may vote to terminate any existing plan. The exercise price of the options will be determined at the date of grant.

 

F-19

-38-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

_________________________________________________________________________________________________________________________

The following is a summary of the Company's open stock option plans:

  Number of        
  securities to be       Number of securities  
  issued upon     Weighted-average   remaining available  
Equity compensation   exercise of     exercise price of   for future issuance  
plans not approved by   outstanding     outstanding   under equity  
security holders   options     options   compensation plans  
 
2003 Stock Option Plan   NIL   $ 0.05   -  
 
2005 Stock Option Plan   NIL   $ 0.05   -  
 
2006 Stock Option Plan   NIL   $ 0.04   147,805  
 
Total   -       147805  

The following is a summary of stock option activity:

  Number of     Weighted Average  
      Shares     Exercise Price  
 
            Options outstanding at July 1, 2003   3,309,000   $   0.05  
            Granted   19,918,600     0.05  
            Exercised   (16,918,600 )     0.05  
            Options outstanding and exercisable at June 30, 2004   6,309,000   $   0.05  
 
            Options outstanding at July 1, 2004   6,309,000   $   0.05  
            Granted   11,740,000     0.04  
            Exercised   (11,740,000 )     0.04  
            Options outstanding and exercisable at June 30, 2005   6,309,000   $   0.05  
 
            Options outstanding at July 1, 2005   6,309,000   $   0.04  
            Granted   8,016,000     0.04  
            Exercised   (8,400,000 )     0.04  
            Options outstanding and exercisable at June 30, 2006   5,925,000   $   0.04  
 
            Options outstanding at July 1, 2006   5,925,000   $   0.04  
            Granted   375,000     0.025  
            Exercised   (6,300,000 )     0.035  
            Options outstanding and exercisable at June 30, 2007 and June          
            30, 2008   NIL   $   0  
 
F-20

 

-39-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008
_____________________________________________________________________________________________________________________

NOTE 7 – RELATED PARTIES

Periodically, loans and accrued wages are repaid, at the Company’s discretion, by the issuance of its common stock options.

At June 30, 2007, the Company owed its officers and directors $450,000 for accrued wages and approximately $263,990 for loans made to the Company.

At June 30, 2008, the Company owed its officers and director $750,000 for accrued wages and approximately $58,910 for loans made to the Company.

NOTE 8 – COMMITMENTS AND CONTINGENCIES

Lease Commitments

The Company has no long term lease commitments. The Company rents its premises on a month to month tenancy of the facility.

NOTE 9 – JOINT VENTURES

First American Scientific Corp ( Malaysia ) Bhd. Sd, ( Joint venture )

On July 8, 2004, the Company entered into a joint venture agreement with two Malaysian companies to sell and market the KDS Micronex Machine. Under the terms of the agreement, the joint venture ordered one KDS Micronex Machine from FASC at a cost of $140,000 and set up a demonstration plant in Malaysia for the KDS System utilizing the KDS Micronex Machine acquired from the Company. At September 9, 2004, this KDS machine had been sold, shipped and paid for.

In June 2005, FASC designed, manufactured and sold one large scale KDS machine to a biomass power plant in Malaysia. FASC earned a royalty of approximately $ 14,000 USD on the sale.

The joint venture with FASC Bhd. is also accounted for using the cost method. According to APB 18, the cost method is generally followed for investments in noncontrolled corporations. FASC received stock in FASC Bhd. for the use of FASC’s technology license. While FASC holds 50% of the outstanding shares and two other companies own the other 50%, FASC does not influence the operating or financial decisions of FASC Bhd. FASC does not exercise its voting rights. FASC Bhd. issued its stock to FASC because it did not have the cash to pay FASC for the use of the technology license. FASC does not exercise significant control over FASC Bhd. and does not actively manage FASC Bhd. because of the presence, involvement and longstanding participation of the other two owners of the joint venture.

 

F-21

-40-

 


 

FIRST AMERICAN SCIENTIFIC CORP.
Unaudited Notes to Consolidated Financial Statements
June 30, 2008

__________________________________________________________________________________________________________________________

Alternative Green Energy Systems Inc - (AGES)

In January 2002, FASC entered into a joint venture agreement with Thermix Combustion Systems Inc. to combine FASC's KDS System and Thermix's suspension dust burning technology and engineering expertise specifically for the processing of biomass pulp sludge. A new company called AGES was incorporated to manage the agreement. Under the original joint venture agreement, FASC retained ownership of all existing KDS technology and all new AGES developed intellectual property which was to be licensed to AGES for use in its designated territories. The license agreement was conditional upon AGES achieving pre-defined sales results, the purchase of one test machine, and the payment of royalties before the end of AGES’s second year of business. In March 2002, Hydro Quebec Capitech Inc. was admitted as a shareholder in AGES after agreeing to invest $1,000,000 CDN in the joint venture. By March 1, 2003, Hydro Quebec Capitech Inc.’s full investment had been received.

In February 2003, FASC deferred the payment terms of the joint venture agreement with AGES for one additional year, until February 21, 2004, then again in 2005. On June 30, 2006, the amount still remains unpaid.

In February 2004, the Company finalized its agreement with AGES by granting AGES exclusive rights to the KDS technology for 20 years for applications in the pulp and paper industry in North America and the European Economic Community at which point FASC is scheduled to relinquish management control over AGES. AGES agreed to purchase the existing test machine in its possession for $100,000 to be paid in four equal installments payable upon closing of the first four sales made by AGES. In addition, AGES agreed to pay a minimum of $500,000 in royalties at $25,000 per machine sold, a minimum of one per year, to maintain the exclusive rights in the territory. During the year ended June 30, 2004, FASC changed its accounting for AGES to the equity method. The balance of its investment in AGES has been netted with its share of accumulated losses from AGES resulting in a zero balance at the financial statement reporting dates.

In September 2005, AGES issued a cash call to all its shareholders. In October 2005, AGES received $ 700,000 Cdn in new funding from its other shareholders. FASC did not participate in the September cash call by AGES and its shareholdings in AGES were diluted 12 %.

In June 2007, Hydro Quebec exercised its put option and forced the sale of 100% AGES to a third party for one dollar plus the assumption of AGES debts. Being unwilling to assume AGES debts which exceeded $ 1.200,000 Cdn, FASC‘s shareholdings were purged, and a new group has now taken over 100 % control of AGES. The debt that was due to FASC by AGES has not been paid and FASC is in a position to cancel the license on June 30, 2008. Subsequently, on September 16, 2008, the license was cancelled.

 

F-22

-41-

 


 

ITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

 

None.


PART III

ITEM 9A. CONTROLS AND PROCEDURES.

Evaluation of Our Disclosure Controls and Internal Controls

      The Company maintains disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the specified time periods. As of the end of the period covered by this report, First American Scientific Corp.’s Principal Executive Officer and their Principal Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures. Based on the evaluation, which disclosed no significant deficiencies or material weaknesses, First American Scientific Principal Executive and Principal Financial Officer each concluded that the Company’s disclosure controls and procedures are effective. There were no changes in the Company’s internal controls over financial reporting that occurred during the Company’s most recent quarter that may have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

CEO and CFO Certifications

      Appearing immediately following the signatures section of this report there are two separate forms of "Certifications" of the CEO and the CFO. The first form of Certification is required in accordance with Section 302 of the Sarbanes-Oxley Act of 2002 (the Section 302 Certification). This section of the report which you are currently reading is the information concerning the Controls Evaluation referred to in the Section 302 Certifications.

Disclosure Controls and Internal Controls

      Disclosure Controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934 (Exchange Act), such as this quarterly report, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's (SEC) rules and forms. Disclosure Controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Internal Controls are procedures which are designed with the objective of providing reasonable assurance that (1) our transactions are properly authorized; (2) our assets are safeguarded against unauthorized or improper use; and (3) our transactions are properly recorded and reported, all to permit the preparation of our financial statements in conformity with generally accepted accounting principles.

 

 

-42-

 


 

Limitations on the Effectiveness of Controls

      Our management, including our CEO and CFO, confirm that the control systems are at the "reasonable assurance" level, however, management does not expect that our Disclosure Controls or our Internal Controls will prevent all error and all fraud as a control system. No matter how well conceived and operated, they cannot provide absolute assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. However, upon discovery that the controls have become inadequate, they will be changed.

Scope of the Controls Evaluation

      Our CEO/CFO evaluation of our Disclosure Controls and our Internal Controls included a review of the controls' objectives and design, the controls' implementation by us and the effect of the controls on the information generated for use in this quarterly report. In the course of the Controls Evaluation, we sought to identify data errors, controls problems or acts of fraud and to confirm that appropriate corrective action, including process improvements, were being undertaken. This type of evaluation will be done on a quarterly basis so that the conclusions concerning controls effectiveness can be reported in our Quarterly Reports on Form 10-QSB and Annual Report on Form 10-KSB. The overall goals of these various evaluation activities are to monitor our Disclosure Controls and our Internal Controls and to make modifications as necessary; our intent in this regard is that the Disclosure Controls and the Internal Controls will be maintained as dynamic systems that change (including with improvements and corrections) as conditions warrant.

      Among other matters, we sought in our evaluation to determine whether there were any "significant deficiencies" or "material weaknesses" in our Internal Controls, or whether we had identified any acts of fraud involving personnel who have a significant role in our Internal Controls. This information was important both for the Controls Evaluation generally and because items 5 and 6 in the Section 302 Certifications of the CEO and CFO require that the CEO and CFO disclose that information to our Board of Directors Audit Committee and to our independent auditors and to report on related matters in this section of the quarterly report. In the professional auditing literature, "significant deficiencies" are referred to as "reportable conditions"; these are control issues that could have a significant adverse effect on the ability to record, process, summarize and report financial data in the financial statements. A "material weakness" is defined in the auditing literature as a particularly serious reportable condition where the internal control does not reduce to a relatively low level the risk that misstatements caused by error or fraud may occur in amounts that would be material in relation to the financial statements and not be detected within a timely period by employees in the normal course of performing their assigned functions. We also sought to deal with other controls matters in the Controls Evaluation, and in each case if a problem was identified, we considered what revision, improvement and/or correction to make in accord with our on-going procedures. In accord with SEC requirements, our CEO and CFO note that, since the date of the Controls Evaluation to the date of this Quarterly Report, there have been no significant changes in Internal Controls or in other factors that could significantly affect Internal Controls, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

-43-

 


 

Conclusions

      Based upon the Controls Evaluation, our CEO and CFO have concluded that, our disclosure controls are effective to ensure that material information relating to us and our subsidiary is made known to management, including our CEO and CFO, particularly during the period when our periodic reports are being prepared. Our internal controls are effective to provide reasonable assurance that our financial statements are fairly presented in conformity with generally accepted accounting principles.


ITEM 9B. OTHER INFORMATION.

None.


ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS.

Officers and Directors

The directors and officers of the Company are:

Name   Age   Position  
John Brian Nichols   71   President, Chief Executive Officer and member of the Board of Directors  
Cal Kantonen   58   Treasurer, Chief Financial Officer and Chairman of the Board of  
    Directors  
David Gibson   67   Secretary and member of the Board of Directors  

John Brian Nichols - President, Chief Executive Officer and a member of the Board of Directors.

      Since April 2001, Mr. Nichols has been the President, Chief Executive Officer and a member of the Board of Directors. For the past 32 years, Mr. Nichols has been a self-employed producer and marketer of a live entertainment show and circus which plays in over in 260 cities annually in Canada and the United States.

Calvin L. Kantonen - Chairman of the Board of Directors, Treasurer and Chief Financial Officer.

      Since February 2000, Mr. Kantonen has been the chairman of the Board of Directors, Treasurer and Chief Financial Officer of the Company. From September 1999 to August 2002, Mr. Kantonen was the President, Secretary/Treasurer and sole member of the Board of Directors of VMH VideoMovieHouse.com Inc., a previous subsidiary of the Company. Prior to joining the Company in 1999, Mr. Kantonen spent five years as a commercial lender with one of Canada’s largest financial institutions. Mr. Kantonen, CGA has been a member in good standing of the Certified General Accountants of British Columbia since 1984, during which time he practiced in the field of public accounting for ten years providing taxation and business advice to small business.

 

-44-

 


 

David L. Gibson - Secretary and member of the Board of Directors

      Since April 2001, Mr. Gibson has been the Secretary and a member of the Board of Directors. Mr. Gibson received a BA in Economics and Political Science in 1968 and obtained his law degree from the University of British Columbia in 1971. Mr. Gibson is retired from the practice of law in Canada after 30 years specializing in the areas of corporate law, commercial practices and estate planning.

      During the past five years, Messrs. Nichols, Kantonen, and Gibson have not been the subject of the following events:

* Any bankruptcy petition filed by or against any business of which Messrs. Nichols, Kantonen, and Gibson were general partners or executive officers either at the time of the bankruptcy or within two years prior to that time.

*       Any conviction in a criminal proceeding or being subject to a pending criminal proceeding.
 
*       An order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of

competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting Messrs. Nichols, Kantonen or Gibson’s involvement in any type of business, securities or banking activities.

* Found by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission or the Commodity Future Trading Commission to have violated a federal or state securities or commodity law, and the judgment has not been reversed, suspended or vacated.

Involvement in Certain Legal Proceedings

      Other than as described in this section, to our knowledge, during the past five years, no present or former director or executive officer of our company: (1) filed a petition under the federal bankruptcy laws or any state insolvency law, nor had a receiver, fiscal agent or similar officer appointed by a court for the business or present of such a person, or any partnership in which he was a general partner at or within two yeas before the time of such filing, or any corporation or business association of which he was an executive officer within two years before the time of such filing; (2) was convicted in a criminal proceeding or named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (3) was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from or otherwise limiting the following activities: (i) acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, associated person of any of the foregoing, or as an investment advisor, underwriter, broker or dealer in securities, or as an affiliated person, director of any investment company, or engaging in or continuing any conduct or practice in connection with such activity; (ii) engaging in any type of business practice; (iii) engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of federal or state securities laws or federal commodity laws; (4) was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any federal or state authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described above under this Item, or to be associated with persons engaged in any such activity; (5) was found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission to have violated any federal or state securities law and the judgment in subsequently reversed, suspended or vacate; (6) was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated.

 

-45-

 


 

Audit Committee and Charter

      We do not have a separately designated, independent audit committee. Audit committee functions are performed by our board of directors, none of whom are deemed independent. All directors also hold positions as our officers. Audit committee responsibilities that the board currently fulfills are: (1) selection and oversight of our independent accountant; (2) establishing procedures for the receipt, retention and treatment of complaints regarding accounting, internal controls and auditing matters; (3) establishing procedures for the confidential, anonymous submission by future employees of concerns regarding accounting and auditing matters; (4) engaging outside advisors; and, (5) funding for the outside auditors and any outside advisors engagement by the audit committee. Specifically with respect to audit committee responsibilities, our board met once last year. All directors participated in the meeting.

Audit Committee Financial Expert

      None of our directors or officers have the qualifications or experience to be considered a financial expert. Because of our limited operations, we believe the services of a financial expert are not warranted at this time.

Code of Ethics

      We have adopted a corporate code of ethics. We believe our code of ethics is reasonably designed to deter wrongdoing and promote honest and ethical conduct; provide full, fair, accurate, timely and understandable disclosure in public reports; comply with applicable laws; ensure prompt internal reporting of code violations; and provide accountability for adherence to the code.

Disclosure Committee and Charter

      We have a disclosure committee and disclosure committee charter. Our disclosure committee is comprised of all of our officers and directors. The purpose of the committee is to provide assistance to the Chief Executive Officer and the Chief Financial Officer in fulfilling their responsibilities regarding the identification and disclosure of material information about us and the accuracy, completeness and timeliness of our financial reports.

Section 16(a) of the Securities Exchange Act of 1934

      Our officers, directors and owners of 10% or more of our outstanding shares of common stock have filed all reports required by section 16(a) of the Securities Exchange Act of 1934.

 

-46-

 


 

ITEM 11. EXECUTIVE COMPENSATION

Compensation Discussion and Analysis

      We have no compensation policies. Compensation arrangements and policies for these directors and officers is established by the board of directors on a case by case basis.

      We do not currently have any long-term incentive plans that provide compensation intended to serve as incentive for performance. While we have granted some stock options, no formal plans have been adopted.

Executive Officer Compensation Table                  
              Non-   Nonqualified      
              Equity   Deferred   All    
              Incentive   Compensa-   Other    
        Stock  Option   Plan   tion   Compen-    
Name and     Salary Bonus  Awards  Awards    Compensation  Earnings   sation   Total  
Principal Position   Year  (US$) (US$)   (US$)   (US$)     (US$)   (US$)   (US$)   (US$)  
(a)   (b)   (c)   (d)       (e)   (f)     (g)   (h)   (i)   (j)  
 
Brian Nichols   2008  150,000 0                   0   0     0   0   0   150,000  
President and CEO   2007  150,000 0                   0   0     0   0   0   150,000  
  2006  150,000 50,000                  0   0     0   0   0   200,000  
 
Cal Kantonen   2008  150,000 0                   0   0     0   0   0   150,000  
CFO and Treasurer   2007  150,000 0                   0   0     0   0   0   150,000  
  2006  150,000 50,000                  0   0     0   0   0   200,000  
 
David Gibson   2008   0   0                   0   0     0   0   0   0  
Secretary   2007   0   0                   0   0     0   0   0   0  
  2006   0   0                   0   0     0   0   0   0  

Future Compensation of Our Officers

      The Company plans to pay the following salaries in 2008, subject to the Company beginning able and generating sufficient funds to pay the same:

Cal Kantonen   Treasurer and CFO   $   150,000  
Brian Nichols   President and CEO   $   150,000  

Employment Agreements

      We have not entered into employment agreements with any of our executive officers. We anticipate that we may enter into employment agreements with our new officers as they are appointed.

 

 

-47-

 


 

Compensation of Directors

      The Company does not have any plans to pay its directors any money. The directors did not receive any other compensation for serving as members of the board of directors. There are no contractual arrangements with any member of the board of directors. The board has not implemented a plan to award options to any directors. We have no director’s service contracts.

      Director's Compensation Table      
  Fees              
  Earned         Nonqualified      
  or       Non-Equity   Deferred      
  Paid in   Stock   Option   Incentive Plan   Compensation   All Other    
  Cash   Awards Awards   Compensation   Earnings   Compensation   Total  
Name   (US$)   (US$)   (US$)   (US$)   (US$)   (US$)   (US$)  
(a)   (b)   (c)   (d)   (e)   (f)   (g)   (h)  
 
Brian Nichols   2008   0   0   0   0   0   0  
Cal Kantonen   2008   0   0   0   0   0   0  
David Gibson   2008   0   0   0   0   0   0  

Pension Benefits and Compensation Plans

     We do not have any pension benefits or compensation plans.

Option/SAR Grants

      There are no stock option, retirement, pension, or profit sharing plans for the benefit of the Company’s officers and directors, other than three incentive stock option plans. Under each Plan, the board of directors is vested with discretionary authority to grant options to persons furnishing services to the Company.

      The 2001 Plan registered 30,000,000 shares. All shares have been issued as a result of the exercise of options. No shares remain in the Plan.

      The 2001A Plan registered 20,000,000 shares. All shares have been issued as a result of the exercise of options. No shares remain in the Plan.

      The 2003 Plan registered 10,000,000 shares. All shares have been issued as a result of the exercise of options. No shares remain in the Plan.

      The 2004 Plan registered 10,000,000 shares, all 10,000,000 options have been granted and no shares remain in the Plan.

      The 2005 Plan registered 10,000,000 shares, 10,000,000 options have been granted and -0- shares remain in the Plan.

 

-48-

 


 

      The 2006 Plan registered 5,000,000 shares, 3,281,493 options have been granted and 1,718,507 shares remain in the Plan.

      Information concerning individual grants of stock options, whether or not in tandem with stock appreciation rights ("SARs"), and freestanding SARs made during fiscal 2008 to each of the named executive officers is reflected in the table below.

Option/SAR Grants in Fiscal 2008
Individual Grants
  Number of Securities   Percent of Total        
  Underlying   Options/SARs     Exercise    
  Options/SARs Granted   Granted to Employees in     or Base   Expiration  
Name   (#)   Fiscal Yr     Price   Date  
Brian Nichols [1]                                                                 Nil   50 %   $ 0.0   n/a  
Cal Kantonen [1]                                                                 Nil   50 %   $ 0.0   n/a  

Aggregated Option/SAR Exercises and Fiscal 2008 Year-End Option/SAR Value Table.

      The following table sets forth certain information with respect to each exercise of stock options and SARs during fiscal 2008 by each of the named executive officers, and the fiscal 2008 year-end value of unexercised options and SARs. The dollar values are calculated by determining the difference between the exercise or base price of the options and the fair market value of the underlying stock at the time of exercise and at fiscal year-end if unexercised, respectively. The unexercised options, some of which may be exercisable, have not been exercised and it is possible they might never be exercised. Actual gains realized, if any, on stock option exercises and common stock holdings are dependent on the future performance and value of the common stock and overall stock market conditions. There can be no assurance that the projected gains and values shown in this Table will be realized.

  Aggregated Option/SAR Exercises in Fiscal 2008
and Option/SAR Values at June 30, 2008

      Number of Securities   Value of Unexercised  
  Shares     Underlying Unexercised   In-the-Money  
  Acquired on   Value   Options/SARs   Options/SARs  
Name   Exercise (#)   Realized   at FY-End (#)   at FY-End ($)  
      Exercisable   Unexercisable   Exercisable   Unexercisable  
Brian Nichols   nil                       nil                                 nil                                       nil                                 nil                                         nil  
Cal Kantonen   nil                       nil                                 nil                                       nil                                 nil                                         nil  

Long-Term Incentive Plan Awards.

      The Company does not have any formalized long-term incentive plans, excluding restricted stock, stock option and SAR plans, which provide compensation intended to serve as incentive for performance to occur over a period longer than one fiscal year, whether such performance is measured by reference to financial performance of the Company or an affiliate, the Company’s stock price, or any other measure.

 

-49-

 


 

Potential Payments Upon Termination or Change-in-Control

      SEC regulations state that we must disclose information regarding agreements, plans or arrangements that provide for payments or benefits to our executive officers in connection with any termination of employment or change in control of the company. We currently have no employment agreements with any of our executive officers, nor any compensatory plans or arrangements resulting from the resignation, retirement or any other termination of any of our executive officers, from a change-in-control, or from a change in any executive officer's responsibilities following a change-in-control.

Family Relationships

There are no familial relationships among the executive officers and directors.

Director Independence

Messrs. Nichols, Kantonen and Gibson are not independent because they are our officers.


ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.

      The following table sets forth, as of June 30, 2008, the total number of shares owned beneficially by each of our directors and officers individually and as a group, and each person who is known by us to beneficially own more than 5% of our total outstanding shares. Percentage of beneficial ownership is based on 199,852.185 shares of common stock outstanding as of June 30, 2008. The stockholders listed below have direct ownership of their shares and possess sole voting and dispositive power with respect to the shares. Unless provided otherwise, the address of each person listed on the table is c/o First American Scientific Corp., # 26 – 7621 Vantage Way, Delta, British Columbia, Canada V4G 1A6.

  Number of     Percent of  
Name of owner       Shares   Position         Class  
 
Brian Nichols           7,936,500   President, Principal Executive Officer and a   3.9 %  
    Director      
 
Cal Kantonen           9,805,600     Chairman of Board of Directors, 4.9 %  
    Treasurer and Principal Financial      
    Officer      
 
David Gibson                 450,000    Secretary and a Director   0.2 %  
 
All officers and directors          
as a group (3)         18,192,100     9.0 %  

 

-50-

 


 

Future Sales of Shares

      A total of 199,852.185 shares of common stock were issued and outstanding as of June 30, 2008. Of the 199,852.185 shares outstanding, all are free trading with the exception of approximately 12,000,000 shares which may only be resold in compliance with Rule 144 of the Securities Act of 1933. Under Rule 144, the restricted shares can be publicly sold, subject to volume restrictions and restrictions on the manner of sale, commencing one year after their acquisition.


ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

      During the year ended June 30, 2008, no related party wages were paid with stock.   

     At June 30, 2008, the Company owned its officers a total of $58,910 for loans and $750,000 for unpaid salaries.

 

      During the year ended June 30, 2008, we issued stock options from our stock option plan to acquire up to 3,750,000 shares of common stock to its officers and employees at exercise prices ranging from $0.04 which were equal to the fair market value of the stock on the date of grant. All of these options have been exercised.

PART IV

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

(1) Audit Fees

      The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for our audit of annual financial statements and review of financial statements included in our Form 10-QSBs or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years was:

2008   $   45,000   Williams & Webster, P.S.  
2007   $   30,000   Williams & Webster, P.S.  

(2) Audit-Related Fees

      The aggregate fees billed in each of the last two fiscal years for assurance and related services by the principal accountants that are reasonably related to the performance of the audit or review of our financial statements and are not reported in the preceding paragraph:

2008   $ -0- Williams & Webster, P.S.  
2007   $ -0- Williams & Webster, P.S.  

 

-51-

 


 

(3) Tax Fees

      The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning was:

2008   $   -0-          Williams & Webster, P.S.  
2007   $   -0-          Williams & Webster, P.S.  

(4) All Other Fees

      The aggregate fees billed in each of the last two fiscal years for the products and services provided by the principal accountant, other than the services reported in paragraphs (1), (2), and (3) was:

2008   $   -0-          Williams & Webster, P.S.  
2007   $   -0-          Williams & Webster, P.S.  

      (5) Our pre-approval policies and procedures for the board, acting in lieu of a separately designated, independent audit committee, described in paragraph (c)(7)(i) of Rule 2-01 of Regulation S-X were that the audit committee pre-approve all accounting related activities prior to the performance of any services by any accountant or auditor.

      (6) The percentage of hours expended on the principal accountant’s engagement to audit our financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant’s full time, permanent employees was 0%.

ITEM 15.

EXHIBITS

The following exhibits are filed as part of this report pursuant to Item 601 of Regulation S-K:

      Incorporated by reference    
Exhibit   Document Description       Form   Date   Number   Filed  
              herewith  
3.1   Articles of Incorporation.     10-SB 1995   3.1    
3.2   Bylaws.     10-SB 1995   3.2    
3.3   Articles of Incorporation of First American Scientific     10-KSB 6/30/97   3.3    
  (Canada)              
3.4   Amended Articles of Incorporation     10-KSB 6/30/98   3.4    
3.5   Amended Articles of Incorporation     S-8   6/27/00   3.5    
4.1   Specimen Stock Certificate.     10 -SB 6/18/05   4.1    
10.1   1996 Nonqualified Stock Option Plan     S-8   6/26/96   10.1    
10.1   1998 Nonqualified Stock Option Plan     S-8   9/8/98   10.1    
10.1   2003 Nonqualified Stock Option Plan     S-8   7/17/03   10.1    

 

-52-

 


 

10.1   Technology License Agreement - Malaysia     10-KSB 9/28/06   10.1    
10.2   Technology License Agreement - Japan     10-KSB 9/28/06   10.2    
10.1   Technology License Agreement - Korea     10-KSB 9/28/06   10.3    
10.1   Technology License Agreement - Alternative Green Energy     10-KSB 9/28/06   10.4    
  Systems, Inc.              
10.11   1999 Nonqualified Stock Option Plan     S-8   9/13/99   10.11    
10.14   2001 Nonqualified Stock Option Plan   S-8   6/27/00   10.1    
10.16   2001A Nonqualified Stock Option Plan   S-8   6/30/00   10.16    
14.1   Code of Ethics.     10-KSB 6/30/03   14.1    
281   Consultant and Employee Stock Compensation Plan     10-KSB     28.1    
31.1   Certification of Principal Executive Officer pursuant to             X  
  15d-15(e), promulgated under the Securities and Exchange              
  Act of 1934, as amended.              
31.2   Certification of Principal Financial Officer pursuant to             X  
  15d-15(e), promulgated under the Securities and Exchange              
  Act of 1934, as amended.              
32.1   Certification pursuant to 18 U.S.C. Section 1350, as adopted             X  
  pursuant to Section 906 of the Sarbanes-Oxley Act of 2002              
  (Chief Executive Office).              
32.2   Certification pursuant to 18 U.S.C. Section 1350, as adopted             X  
  pursuant to Section 906 of the Sarbanes-Oxley Act of 2002              
  (Chief Financial Office).              
99.1   Representative Agreement Between Environmental     10-KSB